Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1050.Time spend outdoors in summer,49908,0.0581647194278536,0.020421290226136,0.018138990584627,0.0981904482710801,0.0044003947722023
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1060.Time spent outdoors in winter,47766,0.0216410410028399,0.0226066321932463,-0.022667958095923,0.0659500401016027,0.338434358992256
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1070.Time spent watching television (TV),50695,0.0741266613486456,0.0201428897202697,0.034646597496917,0.113606725200374,0.000233750622076497
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1080.Time spent using computer,47772,-0.0808165883598666,0.0202114876789155,-0.120431104210541,-0.0412020725091922,6.3971260612449e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X1090.Time spent driving,45086,-0.048803125382818,0.0218873585351771,-0.0917023481117651,-0.00590390265387095,0.0257781033888056
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1160.Sleep duration,51750,0.0211044623872156,0.0185182547412958,-0.0151913169057242,0.0574002416801554,0.254440935940106
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35915,-0.03042490714188,0.0254198737784074,-0.0802478597475585,0.0193980454637986,0.231386465389758
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35915,0.0445100696124557,0.0280374550936609,-0.0104433423711197,0.099463481596031,0.112437746493274
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35915,-0.0512274043901307,0.029411412596947,-0.108873773080147,0.00641896429988539,0.0815937775196647
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35915,-0.0179065689501286,0.0302272636629678,-0.0771520057295456,0.0413388678292883,0.553602450951416
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35915,-0.0360964193835378,0.0311352657850686,-0.0971215403222723,0.0249287015551967,0.246354675161822
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35915,-0.0692848095142665,0.081379751235792,-0.228789121936419,0.0902195029078857,0.394588099084144
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35915,-0.115305490863163,0.0992229012658235,-0.309782377344177,0.0791713956178514,0.245238666313197
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35915,-0.00390672584650888,0.0491812628385548,-0.100302001010076,0.0924885493170586,0.936688605644181
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35915,0.0377555972891508,0.0379155669528831,-0.0365589139385001,0.112070108516802,0.319389551438522
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35915,0.0804034981202347,0.0255650340951835,0.0302960312936749,0.130510964946794,0.00166719525887197
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35915,0.0145966893672979,0.040138411003715,-0.0640745961999834,0.0932679749345792,0.716123266355689
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35915,-0.00171944488699822,0.0190415730240569,-0.0390409280141498,0.0356020382401534,0.928051674586559
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35915,0.00328855552566455,0.0261184911285937,-0.047903687086379,0.0544807981377081,0.899807345096597
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35915,0.0117468535872787,0.0414713097950098,-0.0695369136109405,0.0930306207854979,0.776991275643127
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35915,-0.0807976234788147,0.0386104981900076,-0.15647419993123,-0.0051210470263998,0.0364162517960087
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35915,0.086894704555784,0.0468504198702823,-0.00493211838996922,0.178721527501537,0.0636755368218023
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35915,0.0888909182607103,0.0454311703948372,-0.00015417571317064,0.177936012234591,0.0504317541952019
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35915,0.0426306031500424,0.0293520787891404,-0.0148994712766727,0.100160677576758,0.146436677868581
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35915,-0.00293732009276693,0.0284950438435456,-0.0587876060261162,0.0529129658405824,0.917900884093425
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35915,-0.0445978610890497,0.0315347514001036,-0.106405973833253,0.0172102516551534,0.157332570723863
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120040.Fatigue severity over the past week,35920,0.0496401447068768,0.0343194516409321,-0.0176259805093501,0.116906269923104,0.148103868618695
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120041.Waking unrefreshed severity over the past week,35923,0.0322557729183215,0.0335755877790177,-0.0335523791285531,0.0980639249651962,0.336739166308638
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120042.Cognitive symptoms severity over the past week,35923,0.0247775184088435,0.0369985129770526,-0.0477395670261796,0.0972946038438666,0.503076819351552
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120098.Mobility problems today,35925,0.0396598778246024,0.0396306978746225,-0.0380162900096578,0.117336045658863,0.316987384851064
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120099.Self-care problems today,35925,0.0516742763948103,0.0597542645533937,-0.0654440821298413,0.168792634919462,0.38718803250115
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120100.Problems doing usual activities,35925,0.0541684984956906,0.0381963721825428,-0.0206963909820933,0.129033387973475,0.156187139501579
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120101.Pain or discomfort today,35925,-0.00634372035950761,0.033766401215653,-0.0725258667421875,0.0598384260231723,0.850983149771114
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120102.Anxiety or depression today,35925,0.0192488879632509,0.0433072317906443,-0.0656332863464119,0.104131062272914,0.656713903390669
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120103.Scale to indicate how health is today,35909,-0.00750359453094677,0.00833848141015975,-0.0238470180948599,0.00883982903296633,0.368216194358837
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35909,0.0539775583885474,0.042336187531577,-0.0290013691733435,0.136956485950438,0.202358815407844
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35907,0.00951853986059743,0.0450374786676876,-0.0787549183280703,0.0977919980492652,0.832622339185992
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35913,0.0262534220586914,0.0343943241930476,-0.0411594533596819,0.0936662974770648,0.445305068006353
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35918,0.0583985044098844,0.0347414726352233,-0.00969478195515341,0.126491790774922,0.0928162860392094
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35917,0.0289405254069568,0.050387231081058,-0.0698184475119169,0.12769949832583,0.565740327275172
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120109.Feeling bad about self over the last two weeks,35900,-0.0190968085207276,0.047332069358581,-0.111867664463546,0.0736740474220911,0.686618383828007
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120110.Trouble concentrating over the last two weeks,35920,-0.0354599592064804,0.0451492884680993,-0.123952564603955,0.0530326461909943,0.432248297347052
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35912,-0.0421584951246301,0.0658983726567009,-0.171319305531764,0.0870023152825037,0.522355081516722
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35877,-0.00421788080267332,0.0923213186213662,-0.185167665300551,0.176731903695204,0.963561007776951
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33156,0.0360573703119421,0.0489676147043836,-0.0599191545086499,0.132033895132534,0.461554817426713
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49273,0.136857569188657,0.0453751357658205,0.0479223030876491,0.225792835289665,0.00256329697897429
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48063,0.0474088340343059,0.0258050134710963,-0.00316899236904276,0.0979866604376545,0.0661963953748896
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1289.Cooked vegetable intake,50826,-0.0563832446550162,0.0192564384134383,-0.0941258639453551,-0.0186406253646772,0.00341473687403317
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1299.Salad  or  raw vegetable intake,49995,-0.0537224478619572,0.0198480727574197,-0.0926246704664998,-0.0148202252574146,0.00680129591854743
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1309.Fresh fruit intake,50686,-0.031928693221369,0.0202855195619255,-0.0716883115627429,0.00783092512000498,0.115509917603987
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1319.Dried fruit intake,49701,-0.0405684281777456,0.0216269661297774,-0.0829572817921093,0.00182042543661821,0.0606929539576975
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X134.Number of self-reported cancers,51895,0.0297519491371365,0.0400468413022598,-0.0487398598152926,0.108243758089566,0.457532320470962
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X135.Number of self-reported non-cancer illnesses,51896,0.0927941230894175,0.0192012845197631,0.0551596054306818,0.130428640748153,1.35548083599034e-06
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X136.Number of operations, self-reported",51896,0.027199811479894,0.0184960452972082,-0.00905243730263396,0.063452060262422,0.141419746698728
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X137.Number of treatments or medications taken,51896,0.0628664508937459,0.0188602749887067,0.0259003119158807,0.0998325898716111,0.000859643105506783
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1438.Bread intake,51352,0.00913391942180148,0.00450068555238423,0.000312575739128395,0.0179552631044746,0.0424240218713338
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1458.Cereal intake,50699,0.0279124077381126,0.019160511176588,-0.0096421941679999,0.0654670096442251,0.145194810511077
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1488.Tea intake,51043,0.0101221731667077,0.00442553887386725,0.0014481169739279,0.0187962293594875,0.0221923515361361
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1498.Coffee intake,50080,-0.118145950259938,0.0192634775174675,-0.155902366194174,-0.0803895343257014,8.76562305304748e-10
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X1528.Water intake,49782,-0.0218610680401024,0.0194027693418487,-0.0598904959501259,0.0161683598699211,0.259882808209948
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1568.Average weekly red wine intake,46343,-0.133794239014711,0.0213952494169744,-0.175728927871981,-0.0918595501574412,4.10648137872857e-10
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,46335,-0.0993826962381365,0.0222722647538145,-0.143036335155613,-0.0557290573206601,8.1632055261645e-06
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1588.Average weekly beer plus cider intake,46407,0.0143764895449442,0.0222274343429237,-0.0291892817671861,0.0579422608570746,0.517775990109536
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1598.Average weekly spirits intake,46334,-0.00910603615285741,0.0230538307205567,-0.0542915443651485,0.0360794720594337,0.692854904984207
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1608.Average weekly fortified wine intake,46373,-0.062204487920433,0.0406416877201637,-0.141862195851954,0.0174532200110879,0.125896298880393
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X1737.Childhood sunburn occasions,45746,-0.0222191024133406,0.0226735035212513,-0.0666591693149933,0.022220964488312,0.327120215833698
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1807.Father's age at death,45937,0.00207551214252082,0.005133489058141,-0.00798612641143554,0.0121371506964772,0.685991023280638
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1845.Mother's age,37171,-0.00121056236098951,0.0115677368167893,-0.0238833265218966,0.0214622017999176,0.916656075882134
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1873.Number of full brothers,51493,0.0512147812488287,0.0185852708833004,0.0147876503175598,0.0876419121800975,0.00586192623457495
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X1883.Number of full sisters,51496,0.0456069246279121,0.0185549270898957,0.00923926753171655,0.0819745817241077,0.0139809489338917
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20015.Sitting height,51694,0.0110062883957076,0.00580883619949747,-0.000379030555307473,0.0223916073467226,0.0581381003611399
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20016.Fluid intelligence score,36027,-0.0642761965443264,0.0301971069287556,-0.123462526124687,-0.00508986696396539,0.0333239860565802
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20018.Prospective memory result,36371,0.106862462152536,0.0408934442532169,0.0267113114162309,0.187013612888841,0.00898734746800024
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35946,0.00588272950386314,0.00804904706044701,-0.009893402734613,0.0216588617423393,0.464887754547468
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35945,0.016033461659824,0.00812207463018084,0.000114195384669578,0.0319527279349785,0.048412345045858
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20023.Mean time to correctly identify matches,51596,0.0160549687617101,0.00455623701940853,0.00712474420366938,0.0249851933197508,0.000426336507386168
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#1.Illnesses of father_Heart disease,48489,-0.026812840692292,0.0101796110265299,-0.0467648783042906,-0.00686080308029336,0.00844570393347308
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48050,0.00037095361065071,0.0228773632667774,-0.0444686783922329,0.0452105856135343,0.987063133933808
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48011,-0.0031799981080681,0.0301006532615473,-0.0621772785007009,0.0558172822845647,0.915864726602177
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#12.Illnesses of father_Severe depression,48035,-0.0782960142727268,0.0268920373570769,-0.131004407492598,-0.025587621052856,0.00360113212323202
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48056,-0.00603160205314327,0.0180414055784504,-0.041392756986906,0.0293295528806194,0.738141731172835
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#2.Illnesses of father_Stroke,48229,0.00592504403283926,0.0129671129126405,-0.0194904972759361,0.0313405853416147,0.647727462494224
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48176,0.0212863665027695,0.0164396760710236,-0.0109353985964368,0.0535081316019759,0.195398753837586
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48068,-0.00469914290504912,0.0200121821768542,-0.0439230199716834,0.0345247341615852,0.814355479117648
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48191,0.0342276710167344,0.0153861901316788,0.00407073835864395,0.0643846036748248,0.0261214051295076
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48283,-0.00197535216421773,0.0115171176220101,-0.0245489027033575,0.0205981983749221,0.863821027732886
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20107#9.Illnesses of father_Diabetes,48140,0.0145034890773356,0.0158440483628505,-0.0165508457138515,0.0455578238685227,0.359998035405117
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49264,-0.0134400276546569,0.0120354253241909,-0.0370294612900712,0.0101494059807573,0.264133178655923
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49109,-0.00577318596953191,0.0169181159688378,-0.0389326932684541,0.0273863213293903,0.732924269526643
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49033,0.0221588175921947,0.0376137004349439,-0.0515640352602954,0.0958816704446848,0.555790243988193
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49068,-0.00767629280643888,0.0200126631210264,-0.0469011125236506,0.0315485269107728,0.701299843556384
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#2.Illnesses of mother_Stroke,49213,-0.00229674456774674,0.0134695734382147,-0.0286971085066476,0.0241036193711541,0.864607965179097
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49110,-0.00288001921105414,0.0225674173664831,-0.047112157249361,0.0413521188272527,0.898452167126898
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49073,0.026078304625162,0.0205882949470004,-0.0142747534709588,0.0664313627212828,0.205292428854646
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49084,-0.0170659181413767,0.0172343073011725,-0.0508451604516748,0.0167133241689213,0.322073691719555
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49117,0.0299418562206718,0.0205925710844927,-0.0104195831049338,0.0703032955462774,0.145958130827045
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49318,0.00189266016121426,0.0103450325830769,-0.0183836037016165,0.0221689240240451,0.854836276130256
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49168,0.0134965556298874,0.0156264959148377,-0.0171313763631944,0.0441244876229692,0.387764504393311
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46265,0.00273049753064729,0.0166870585899708,-0.0299761373056954,0.03543713236699,0.870024575109593
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46120,-0.056591540321763,0.0685888840815715,-0.191025753121643,0.0778426724781172,0.409335554442464
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46113,0.04563431064049,0.0671399765758939,-0.0859600434482619,0.177228664729242,0.49671031909432
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46167,-0.00457476543908349,0.0216950708417211,-0.0470971042888569,0.0379475734106899,0.832993827150104
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46129,0.0216906419911859,0.0394185157188679,-0.0555696488177953,0.0989509328001671,0.582144421745997
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46165,0.0252048873847247,0.027735088380131,-0.0291558858403321,0.0795656606097815,0.363482660119029
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46134,0.025304198329493,0.0319397097995536,-0.037297632877632,0.087906029536618,0.428226308767796
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46138,0.0127787478060862,0.0310592353572479,-0.0480973534941198,0.0736548491062922,0.680761187279427
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46144,-0.0199645138824077,0.0246057043394058,-0.0681916943876431,0.0282626666228277,0.417159946726082
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46160,0.0155297013957421,0.0311278505401089,-0.0454808856628713,0.0765402884543556,0.617855704200111
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46326,0.0171453655700702,0.0126737826061982,-0.00769524833807822,0.0419859794782186,0.176129917596811
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46227,0.065933035048849,0.017642963142428,0.0313528272896901,0.100513242808008,0.000186762871155221
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20127.Neuroticism score,47353,0.0225005187331904,0.0194509544909083,-0.0156233520689898,0.0606243895353706,0.247376082770418
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36027,0.00755813910943892,0.03050960484388,-0.0522406863845659,0.0673569646034437,0.804350311344401
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X20161.Pack years of smoking,36740,0.0300141090837461,0.00771225788781147,0.0148980836236356,0.0451301345438565,0.000100321523703279
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36740,0.0286161413765453,0.00760301999080068,0.0137142221945759,0.0435180605585146,0.000168536701028335
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20191.Fluid intelligence score,34164,-0.062156613312297,0.0364862431133374,-0.133669649814438,0.00935642318984437,0.0885187239155242
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34165,-0.0664465777944649,0.0374047315592447,-0.139759851650584,0.0068666960616547,0.0757181719918681
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X20240.Maximum digits remembered correctly,33633,-0.00786877511878611,0.0388287000997997,-0.0839730273143934,0.0682354770768212,0.839414011710958
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X20255.Spirometry QC measure,45233,0.00202052366683441,0.0235430596148962,-0.0441238731783621,0.0481649205120309,0.931608572059787
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X20261.avMSE,33703,0.0115411961473276,0.00992660245213671,-0.00791494465886036,0.0309973369535155,0.245024603142179
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X20262.Myopia diagnosis,33703,-0.0545749050476853,0.0457504395994421,-0.144245766662592,0.0350959565672212,0.232970811342041
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X20280.Glucose-lactate,41886,0.0357266959150191,0.0056619607688113,0.0246292528081489,0.0468241390218893,2.87984104315581e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X20281.Spectrometer-corrected alanine,41910,0.0251936535526322,0.0059913954660272,0.0134505184392189,0.0369367886660455,2.62821373024841e-05
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35822,-0.0198921397176742,0.0366510649252546,-0.0917282269711733,0.0519439475358248,0.587322933318384
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35822,-0.0388129100335014,0.0796446834722296,-0.194916489639071,0.117290669572069,0.626042249822993
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35821,-0.115331137910804,0.0973850336942702,-0.306205803951573,0.075543528129966,0.236341262270261
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35821,-0.00890115839537793,0.0357506363580748,-0.0789724056572045,0.0611700888664487,0.803384091345277
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35821,0.0132265125662034,0.050648264253056,-0.0860440853697864,0.112497110502193,0.793988570046085
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35824,-0.0297110720044628,0.0686828743752542,-0.164329505779961,0.104907361771035,0.66533035698313
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35824,-0.0529834081687195,0.0435979823029963,-0.138435453482592,0.0324686371451532,0.224302074383797
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35824,0.00690999696639387,0.0496522579755011,-0.0904084286655882,0.104228422598376,0.889321408865117
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35824,0.0869197560984541,0.0722956541694504,-0.0547797260736687,0.228619238270577,0.229293736176538
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35824,-0.037081843936079,0.0796519513151295,-0.193199668513733,0.119035980641575,0.641552770398104
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35824,0.0476677206682414,0.0522713615940924,-0.0547841480561798,0.150119589392663,0.361837026133494
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35824,0.0321091705840726,0.0769640108007102,-0.118740290585319,0.182958631753464,0.676546562998439
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35824,0.0184543485285355,0.0630460585282968,-0.105115926186926,0.142024623243997,0.769750574534242
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35827,-0.071740416567072,0.105583161600613,-0.278683413304274,0.13520258017013,0.496862916228437
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35827,-0.0325883781523634,0.0469907604521836,-0.124690268638643,0.0595135123339164,0.488014298254134
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35827,-0.0320796421336188,0.0617972410035367,-0.153202234500551,0.0890429502333131,0.603699069429744
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35827,0.121544733272044,0.140622725498019,-0.154075808704074,0.397165275248162,0.387434176799544
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20600.Liking for adding salt to foods,36493,-0.0292010993649814,0.0299672894877865,-0.087936986761043,0.0295347880310802,0.329871759129136
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20601.Liking for aniseed,36493,-0.0250354445288986,0.0298002108127332,-0.0834438577218557,0.0333729686640586,0.400872388197698
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20602.Liking for apple juice,36493,-0.0331860066811857,0.0297622660690176,-0.0915200481764603,0.0251480348140888,0.264868858913499
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20603.Liking for apples,36493,-0.0381907001022587,0.0302203263287882,-0.0974225397066836,0.0210411395021663,0.206359956675469
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20604.Liking for asparagus,36493,-0.0913969365211606,0.0299755421223074,-0.150148999080883,-0.0326448739614381,0.00230327456102042
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20605.Liking for aubergine,36493,-0.120332621228977,0.0294603109060819,-0.178074830604898,-0.0625904118530563,4.45961333599867e-05
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20606.Liking for avocados,36493,-0.096399791259408,0.0299021899169741,-0.155008083496677,-0.0377914990221387,0.00127000321202163
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20607.Liking for bacon,36493,0.00556000173966958,0.0303302065324129,-0.0538872030638598,0.065007206543199,0.854555063923852
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20608.Liking for baked or steamed fish,36493,-0.0540001343017234,0.0300364558187914,-0.112871587706555,0.00487131910310776,0.0722438188055242
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20609.Liking for bananas,36493,0.0329375260562277,0.0306218966169038,-0.0270813913129037,0.0929564434253592,0.282130130077363
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36493,-0.0208308043375775,0.0300726525483423,-0.0797732033323285,0.0381115946571735,0.488529138375358
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20611.Liking for beef steak,36493,0.00830656998314694,0.0302539259131514,-0.0509911248066299,0.0676042647729238,0.783660172018393
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20612.Liking for beetroot,36493,-0.00404132897753417,0.0303527582315843,-0.0635327351114395,0.0554500771563711,0.894081819012327
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20613.Liking for bell pepper,36493,-0.0507275334623703,0.0298875730530082,-0.109307176646266,0.00785210972152581,0.0896834994427282
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20614.Liking for bicycling,36493,-0.0359468651382191,0.0298557085878262,-0.0944640539703586,0.0225703236939203,0.228618061345562
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20615.Liking for biscuits,36493,0.040456534680611,0.0299677866263829,-0.0182803271070995,0.0991933964683216,0.177054495303328
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20616.Liking for bitter foods,36493,-0.083072782815832,0.0294179629651176,-0.140731990227463,-0.0254135754042014,0.00475652455214478
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20617.Liking for bitter or ale,36493,-0.0669318635064335,0.0298753694715269,-0.125487587670626,-0.00837613934224091,0.0250946937712873
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20618.Liking for black olives,36493,-0.0819307888899383,0.0300105396209379,-0.140751446546977,-0.0231101312329,0.00634620585731662
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20619.Liking for black pepper,36493,-0.0169263441109732,0.0300578156080316,-0.0758396627027151,0.0419869744807687,0.573364951445169
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20620.Liking for blue cheese,36493,-0.106664122891516,0.0299926081437097,-0.165449634853187,-0.0478786109298449,0.000378253361222038
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20621.Liking for bolognese sauce,36493,-0.0562501163666037,0.030048389996047,-0.115144960758856,0.00264472802564842,0.0612457593885012
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20622.Liking for broad beans,36493,-0.138897116808341,0.0300085141112766,-0.197713804466443,-0.0800804291502389,3.74049640798646e-06
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20623.Liking for broccoli,36493,-0.041091409239524,0.0302318997173707,-0.100345932685571,0.0181631142065226,0.174119885804338
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20624.Liking for brown rice,36493,-0.0670519915168336,0.0302012508132412,-0.126246443110786,-0.00785753992288091,0.0264353774293267
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20625.Liking for brussel sprouts,36493,-0.0711258665905637,0.0301276295108217,-0.130176020431774,-0.0120757127493532,0.018258850583754
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20626.Liking for burgers (meat),36493,-0.0280442928918508,0.0295253938753477,-0.0859140648875323,0.0298254791038307,0.342224518163727
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20627.Liking for burn of spicy foods,36493,-0.0586792963913396,0.029662909258519,-0.116818598538037,-0.000539994244642447,0.0479404140160295
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20628.Liking for butter on bread,36493,0.0111191807704097,0.0301734838048522,-0.0480208474871007,0.0702592090279201,0.712504113489246
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20629.Liking for butternut squash,36493,-0.0713823334180633,0.0299998436716548,-0.130182027014507,-0.0125826398216199,0.0173633934596028
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20630.Liking for cabbage,36493,-0.0498418642509179,0.030039014224201,-0.108718332130352,0.00903460362851612,0.0971076820489372
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20631.Liking for cake,36493,0.0442388865462504,0.0299562269742655,-0.01447531832331,0.102953091415811,0.139773399111891
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20632.Liking for cake icing,36493,-0.000339822349540175,0.0295455467827137,-0.058249094043659,0.0575694493445787,0.990823509479496
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20633.Liking for capers,36493,-0.0899193597516442,0.029476920976583,-0.147694124865747,-0.0321445946375415,0.00229219451929544
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20634.Liking for cauliflower,36493,-0.0538176532918036,0.0303275522769107,-0.113259655754549,0.0056243491709413,0.0760113698504986
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20635.Liking for cereal or granola bar,36493,0.015831056825818,0.029792358642357,-0.0425619661132018,0.0742240797648377,0.595170604194515
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20636.Liking for cheesecake,36493,-0.0296585487855054,0.0297291543739597,-0.0879276913584664,0.0286105937874556,0.318491832271603
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20637.Liking for cherries,36493,-0.0302331176778929,0.0303522536230434,-0.0897235347790579,0.0292572994232721,0.319244329064866
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20638.Liking for chicken,36493,0.0133286573133077,0.0309014206821396,-0.0472381272236859,0.0738954418503013,0.666241467632832
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20639.Liking for chilli pepper,36493,-0.0441920334389858,0.0295099956999073,-0.102031625010804,0.0136475581328325,0.134296058888846
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20640.Liking for chips or french fries,36493,0.0266492642162503,0.0302530685921514,-0.0326467502243664,0.085945278656867,0.378410678172056
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20641.Liking for cigarette smoking,36493,0.0270531162260656,0.0470971802541337,-0.0652573570720365,0.119363589524168,0.56570641790064
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20642.Liking for cod,36493,-0.0263760601794033,0.0307432260152812,-0.0866327831693544,0.0338806628105479,0.390947780589428
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20643.Liking for coffee with sugar,36493,-0.0145922510869174,0.0311262505088048,-0.0755997020841747,0.0464151999103399,0.639219479564243
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20644.Liking for coffee without sugar,36493,-0.0927631090966541,0.0302479510823904,-0.152049093218139,-0.0334771249751689,0.0021712799690135
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20645.Liking for coriander,36493,-0.103408995305078,0.0299851158529706,-0.1621798223769,-0.0446381682332554,0.000566285130577053
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20646.Liking for corn flakes,36493,0.0366800360103783,0.0296578797634418,-0.0214494083259676,0.0948094803467241,0.216208569933772
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20647.Liking for cream,36493,-0.0266493656836625,0.0298733545746302,-0.0852011406499377,0.0319024092826127,0.372378292575981
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20648.Liking for croissant,36493,-0.0598799057990539,0.0298304561837177,-0.118347599919141,-0.00141221167896716,0.0447474037438125
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20649.Liking for cucumber,36493,-0.00669700661347273,0.0302007418868156,-0.0658904607116312,0.0524964474846858,0.824514451476004
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20650.Liking for curry,36493,-0.0624852774272219,0.0301889267658262,-0.121655573888241,-0.00331498096620252,0.0385028354902923
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20651.Liking for dairy products,36493,0.0359819708367532,0.0301460463412896,-0.0231042799921744,0.0950682216656808,0.2326749327062
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20652.Liking for dark chocolate,36493,-0.064844538069848,0.0300648073487842,-0.123771560473465,-0.00591751566623099,0.0310494099081061
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20653.Liking for diet fizzy drinks,36493,0.0213354981266115,0.029956069725214,-0.0373783985348079,0.0800493947880308,0.476345782256761
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20654.Liking for dried fruit,36493,-0.0575719034953186,0.0300308422684664,-0.116432354341513,0.00128854735087548,0.0552622787219552
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20655.Liking for eggs,36493,-0.00860232790832908,0.0305572735484569,-0.0684945840633047,0.0512899282466465,0.778322887151182
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20656.Liking for exercising alone,36493,-0.0373279969519693,0.0297849909789176,-0.0957065792706478,0.0210505853667092,0.210152429061657
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20657.Liking for exercising with others,36493,-0.031782335075978,0.0296645826836562,-0.0899249171359442,0.0263602469839881,0.28402693591312
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20658.Liking for extra virgin olive oil,36493,-0.0283114813653267,0.0299783640101852,-0.0870690748252897,0.0304461120946363,0.344995680230573
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20659.Liking for fatty foods,36493,-0.0015250571617431,0.0298417072340288,-0.0600148033404395,0.0569646890169533,0.959243234190102
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20660.Liking for fresh tomatoes,36493,-0.0687926373257653,0.0311575962503771,-0.129861525976504,-0.00772374867502623,0.0272804183752404
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20661.Liking for fried chicken,36493,0.027942882259369,0.0298457189366794,-0.0305547268565227,0.0864404913752607,0.349176129925896
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20662.Liking for fried or battered fish,36493,-0.0183399358976354,0.0301811385353991,-0.0774949674270176,0.0408150956317469,0.543429065381447
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20663.Liking for fruit,36493,0.0115249954497707,0.0315242077743836,-0.0502624517880212,0.0733124426875625,0.714679417917102
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20664.Liking for garlic,36493,-0.0736878737933104,0.0300963536284347,-0.132676726905043,-0.0146990206815783,0.0143709124493325
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20665.Liking for gherkins,36493,-0.0734815009730343,0.0298766924886746,-0.132039818250836,-0.0149231836952321,0.0139346757955885
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20666.Liking for globe artichoke,36493,-0.0698597710625643,0.0295565904378505,-0.127790688320751,-0.0119288538043773,0.0181227676699196
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20667.Liking for goat's cheese,36493,-0.0537658393992509,0.0294877637834314,-0.111561856414777,0.00403017761627465,0.0682917083264874
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20668.Liking for going to a cafe,36493,-0.0245318037758012,0.0299084781674764,-0.083152420984055,0.0340888134324525,0.412110319751316
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20669.Liking for going to the gym,36493,-0.0533757969312344,0.0295080864484965,-0.111211646370288,0.00446005250781881,0.0705118889581244
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20670.Liking for going to the pub,36493,-0.0533055563395601,0.0297551034324943,-0.111625559067249,0.00501444638812872,0.0732552687706021
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20671.Liking for grapefruit,36493,-0.0595643692127662,0.0296234283109769,-0.117626288702281,-0.0015024497232515,0.0443892048307785
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20672.Liking for green olives,36493,-0.0510943867626794,0.029987476557473,-0.109869840815327,0.00768106728996772,0.0884471198735356
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20673.Liking for haddock,36493,-0.045468344656708,0.0304164615764999,-0.105084609346648,0.0141479200332318,0.134991066975601
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20674.Liking for ham,36493,0.0116451705020454,0.0299352807651684,-0.0470279797976846,0.0703183208017754,0.697278094975139
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20675.Liking for hard cheese,36493,-0.0592479606904411,0.0301712262733892,-0.118383564186284,-0.000112357194598234,0.0495971982476092
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20676.Liking for herring,36493,-0.0716313660340629,0.0294195241341885,-0.129293633337072,-0.0139690987310534,0.0149210611054929
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20677.Liking for honey,36493,-0.0212067751081491,0.0297237611574763,-0.0794653469768026,0.0370517967605045,0.475581016266264
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20678.Liking for horseradish or wasabi,36493,-0.0901229976064339,0.0295281649713292,-0.147998200950239,-0.0322477942626287,0.00228000696272602
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20679.Liking for ice cream,36493,0.00139325339955971,0.0304386705522872,-0.0582665408829232,0.0610530476820426,0.96349275389746
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20680.Liking for jam,36493,0.0349431252626454,0.0300386183760366,-0.0239325667543864,0.0938188172796772,0.244753806625558
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20681.Liking for kiwi fruit,36493,0.00631007228799228,0.0298742273820372,-0.0522434133808007,0.0648635579567853,0.832720072287545
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20682.Liking for lager,36493,0.0270341974113683,0.0297516826813694,-0.0312791006441156,0.0853474954668523,0.363556806251718
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20683.Liking for lamb,36493,-0.0144342906130904,0.0304315930180993,-0.0740802129285651,0.0452116317023843,0.635285397003494
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20684.Liking for lemons,36493,-0.059548847278834,0.0297293606426324,-0.117818394138394,-0.00127930041927438,0.0452080724456888
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20685.Liking for lentils or beans,36493,-0.0466827176351009,0.0300813746169837,-0.105642211884389,0.0122767766141872,0.12073080733055
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20686.Liking for liver,36493,-0.0440226212388223,0.0301632802008272,-0.103142650432444,0.0150974079547991,0.144473639068604
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20687.Liking for mackerel,36493,-0.0861807425209612,0.0299329354429674,-0.144849295989177,-0.0275121890527452,0.00399850014171519
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20688.Liking for marzipan,36493,0.00420974832592362,0.029666871833549,-0.0539373204678323,0.0623568171196796,0.887162108508692
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20689.Liking for mayonnaise,36493,-0.0743701051217699,0.0298193203632382,-0.132815973033717,-0.0159242372098231,0.0126507197422344
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20690.Liking for melon,36493,-0.0260099929116373,0.0303901373907306,-0.0855746621974693,0.0335546763741948,0.392095955080697
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20691.Liking for milk chocolate,36493,0.0181722989834959,0.0297659134514527,-0.0401688913813515,0.0765134893483432,0.541543595509989
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20692.Liking for mushrooms,36493,-0.0637787894149012,0.0306175534619504,-0.123789194200324,-0.00376838462947832,0.0372761474876967
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20694.Liking for orange juice,36493,-0.0173612508793095,0.0301758736080814,-0.0765059631511492,0.0417834613925301,0.565080846096528
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20695.Liking for oranges,36493,0.0223974037030888,0.030148605718775,-0.0366938635057103,0.0814886709118879,0.457564269718967
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20696.Liking for pasta,36493,-0.0347417511235605,0.0304671136694035,-0.0944572939155912,0.0249737916684703,0.254194590797898
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20697.Liking for pears,36493,0.0198342366030786,0.0302715523736784,-0.0394980060493311,0.0791664792554882,0.512351401598805
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20698.Liking for pizza,36493,0.00173959357972683,0.0300370778175695,-0.0571330789427094,0.0606122661021631,0.95381790291917
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20699.Liking for plain yogurt,36493,-0.0516953687327113,0.02986245680978,-0.11022578407988,0.00683504661445751,0.0834702480138629
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20700.Liking for plums,36493,-0.0209668779848547,0.0298655917601043,-0.0795034378346591,0.0375696818649497,0.482674150535575
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20701.Liking for pollock,36493,-0.0687694336308017,0.0293679053068402,-0.126330528032209,-0.0112083392293948,0.0192233384084775
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20702.Liking for pork chop,36493,0.000641629176365528,0.030138285186695,-0.0584294097895568,0.0597126681422878,0.983015254409502
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20703.Liking for porridge,36493,-0.014728936795055,0.0299886239255227,-0.0735066396890796,0.0440487660989695,0.623333461463079
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20704.Liking for potato crisps,36493,0.0603404463408021,0.0303141359148447,0.000924739947706553,0.119756152733898,0.0465697763435978
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20705.Liking for potatoes,36493,0.0186629066422973,0.0302911846488691,-0.0407078152694861,0.0780336285540807,0.537835244175324
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20706.Liking for prawns,36493,-0.0572596406378256,0.0300842723075045,-0.116224814360534,0.00170553308488317,0.0570367319737599
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20707.Liking for raw carrots,36493,-0.0210984042419112,0.0297102557255454,-0.0793305054639802,0.0371336969801578,0.477639094348483
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20708.Liking for red meat,36493,0.0166979517168281,0.0301245486146081,-0.0423461635678038,0.07574206700146,0.579391216184512
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20709.Liking for red wine,36493,-0.0746645307447229,0.0303084169568693,-0.134069027980187,-0.0152600335092591,0.0137803115321652
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36493,-0.00735332621377835,0.0298421045862968,-0.0658438512029201,0.0511371987753634,0.805373012985332
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20711.Liking for roast chicken,36493,0.0157388345502407,0.030904178410856,-0.0448333551350371,0.0763110242355185,0.610571258122496
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20712.Liking for salad dressing,36493,-0.0289679114830425,0.0298160857244123,-0.0874074395028906,0.0294716165368057,0.331302713610978
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20713.Liking for salad leaves,36493,-0.0144578004772388,0.0300973651654424,-0.0734486362015058,0.0445330352470283,0.630979323281509
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20714.Liking for salami,36493,-0.0370875539116041,0.029427542185767,-0.0947655365957073,0.0205904287724991,0.207598184422736
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20715.Liking for salmon,36493,-0.076701297669043,0.0303861972480684,-0.136258244275257,-0.017144351062829,0.0116151661420334
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20716.Liking for salty foods,36493,0.00540148886891635,0.0296080841002325,-0.0526303559675393,0.063433333705372,0.855247693152553
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20717.Liking for salty pretzels,36493,-0.0444396283799503,0.0296522085865192,-0.102557957209528,0.0136787004496273,0.133992709880057
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20718.Liking for sardines,36493,-0.0941099842083392,0.0295560254110694,-0.152039794014035,-0.0361801744026432,0.00145758675130393
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20719.Liking for sausages (meat),36493,-0.023516804296197,0.0300139165852679,-0.0823440808033222,0.0353104722109281,0.433339476128387
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20720.Liking for savoury biscuits,36493,-0.00856678484855655,0.0298057731361682,-0.0669861001954462,0.0498525304983331,0.773798058285993
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36493,-0.0757227768341201,0.0293434146417984,-0.133235869532045,-0.0182096841361953,0.00988160743254566
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20722.Liking for skimmed milk,36493,-0.0634926171414255,0.0297161230728697,-0.12173621836425,-0.0052490159186009,0.0326580883451325
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20723.Liking for smoked fish,36493,-0.110697071947847,0.0299294336969086,-0.169358761993788,-0.0520353819019066,0.00021826355474413
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20724.Liking for soft cheese,36493,-0.0498877389036113,0.0298164306182709,-0.108327942915422,0.00855246510819974,0.0943349482360411
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20725.Liking for soy sauce,36493,-0.0185916310614781,0.029963868904354,-0.0773208141140119,0.0401375519910558,0.534967446791559
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20726.Liking for soya milk,36493,-0.0333030044036756,0.0297052095418418,-0.0915252151056856,0.0249192062983344,0.262272367728069
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20727.Liking for spicy foods,36493,-0.0434710650936703,0.0298397412606527,-0.10195695796455,0.015014827777209,0.145206515753561
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20728.Liking for spinach,36493,-0.0610585739757344,0.0297852142669295,-0.119437593938916,-0.00267955401255265,0.0404010901763443
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20729.Liking for spirits,36493,-0.0137152067385617,0.029558486547561,-0.0716498403717814,0.0442194268946579,0.642658884460277
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20730.Liking for strawberries,36493,-0.00059979333499653,0.0310447866196718,-0.0614475751095533,0.0602479884395602,0.984586111065632
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36493,-0.0100887924041222,0.0299483998582823,-0.0687876561263556,0.0486100713181111,0.736221981563227
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20732.Liking for sweet foods,36493,0.0193086002220317,0.0299818272813043,-0.0394557812493247,0.0780729816933882,0.519587604987796
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20733.Liking for taking the stairs,36493,-0.040297355791716,0.0305195143623199,-0.100115603941863,0.019520892358431,0.18674651346049
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20734.Liking for tea with sugar,36493,0.00913315006237288,0.0330423973073544,-0.0556299486600417,0.0738962487847875,0.782242722716871
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20735.Liking for tea without sugar,36493,0.010603091003506,0.0307119375522231,-0.0495923065988513,0.0707984886058633,0.729920671061148
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20736.Liking for tomato ketchup,36493,-0.0383054236731853,0.0299853287829922,-0.0970766680878501,0.0204658207414795,0.201473208250032
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20737.Liking for tinned tuna,36493,-0.00047600103625768,0.029844904468823,-0.0589720137951508,0.0580200117226355,0.987275357757384
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20738.Liking for turnip (white),36493,-0.0770538671970599,0.029723613536391,-0.135312149728386,-0.0187955846657337,0.00954999963580016
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20739.Liking for vegetables,36493,-0.0369368427995257,0.0309481143004423,-0.0975951468283927,0.0237214612293413,0.232706130076336
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20740.Liking for vinegar,36493,-0.0112193075539737,0.0300144632033711,-0.070047655432581,0.0476090403246336,0.708565619745902
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20741.Liking for watching television,36493,0.0831924787447534,0.0301461363595786,0.0241060514799794,0.142278906009527,0.00579987139988753
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20742.Liking for whisky,36493,-0.0182257947881162,0.0301129541283279,-0.0772471848796388,0.0407955953034064,0.545031878509342
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20743.Liking for white bread,36493,0.00155709452273738,0.0295947237298002,-0.056448563987671,0.0595627530331457,0.958040856182121
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20744.Liking for white rice,36493,0.00978058451132345,0.030372887034077,-0.0497502740754674,0.0693114430981143,0.747448389634833
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20745.Liking for white wine,36493,-0.0269004687764578,0.0297210708268834,-0.0851537675971493,0.0313528300442336,0.365441360344936
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36493,-0.0436444934485099,0.0300126968980953,-0.102469379368777,0.0151803924717569,0.145930398591735
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20747.Liking for whole milk,36493,0.0594260258019084,0.0296133257359845,0.00138390735937888,0.117468144244438,0.0448122249457666
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20748.Liking for wholemeal bread,36493,-0.0488937581767569,0.0306507879356402,-0.108969302530612,0.0111817861770979,0.110710363142511
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X20749.Liking for working up a sweat,36493,-0.0524458577249101,0.0303191731844243,-0.111871437166382,0.00697972171656142,0.08370661423581
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21001.Body mass index (BMI),51761,-0.152899940630831,0.0232717988933465,-0.19851266646179,-0.107287214799871,5.13210369792897e-11
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21002.Weight,51793,-0.00403780043877515,0.0112213629925208,-0.0260316719041159,0.0179560710265656,0.718976384148428
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X21021.Pulse wave Arterial Stiffness index,36356,0.0216412270031565,0.00865281747322866,0.00468170475562835,0.0386007492506847,0.0124026308075252
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36263,0.00732814139971686,0.0336411689885014,-0.058608549817746,0.0732648326171797,0.827565391260495
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36265,-0.0245203906500014,0.0338031386614112,-0.0907745424263673,0.0417337611263645,0.468236195429437
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36266,-0.0603388504850163,0.0329130965261955,-0.12484851967636,0.00417081870632683,0.0668000320707539
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21040.Satisfaction with bowel habits,36239,0.0945087608793726,0.030514211943753,0.0347009054696168,0.154316616289128,0.00196064080161241
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36239,0.0800026148675184,0.033106263266721,0.0151143388647453,0.144890890870291,0.0156921122051303
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21042.Greatest number of times bowels opened per day,36235,0.0833220482461298,0.0329430537747041,0.0187536628477097,0.14789043364455,0.0114497992358582
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21043.Least number of times bowels opened per week,36201,-0.0312862803624633,0.032897427610475,-0.0957652384789944,0.0331926777540677,0.341621861600871
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21044.Average number of times bowels opened per day,36210,0.0780056876467192,0.036220210422224,0.00701407521916025,0.148997300074278,0.0312989051839246
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36272,0.0596963376510452,0.0331645384574631,-0.0053061577255825,0.124698833027673,0.0718991111013949
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36268,0.0234156994940804,0.0331195464080637,-0.0414986114657245,0.0883300104538853,0.47958458381309
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36270,0.0592518506481933,0.0381585500174291,-0.0155389073859678,0.134042608682354,0.120516857563225
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36270,0.0147780012737182,0.0481252658023012,-0.0795475196987922,0.109103522246229,0.758795647230612
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36270,-0.0323901122280944,0.0404092611171334,-0.111592264017676,0.0468120395614871,0.422837156580255
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36269,-0.151669149718519,0.0985498495188743,-0.344826854775512,0.041488555338475,0.12384325099437
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36272,-0.0144621451894778,0.0410089892249326,-0.0948397640703456,0.06591547369139,0.724354592450532
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36269,-0.0824416315766322,0.0377675409994421,-0.156466011935539,-0.00841725121772567,0.0290756125320984
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36128,0.0614802861846159,0.0375201531822234,-0.0120592140525419,0.135019786421774,0.101339708052698
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36266,-0.0172914354218383,0.0338589590664338,-0.0836549951920486,0.049072124348372,0.609582776531127
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36271,0.0520394705836926,0.057438861335522,-0.0605406976339306,0.164619638801316,0.364965581618514
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36272,-0.0689842954149066,0.0334024441797488,-0.134453086007214,-0.00351550482259905,0.0389331590900636
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36271,-0.0772927591002285,0.0329903465523035,-0.141953838342743,-0.0126316798577137,0.0191604337012482
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X21100.Water hardness (USGS classification),51623,-0.0222277854994808,0.018706605677881,-0.0588927326281275,0.0144371616291659,0.234754319385993
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2139.Age first had sexual intercourse,48840,-0.0129088899178472,0.00459442973845021,-0.0219139722052096,-0.00390380763048477,0.00496379257706655
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2149.Lifetime number of sexual partners,47195,-0.0118487352624544,0.0213416646170467,-0.0536783979118659,0.0299809273869571,0.578769576881786
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22032.IPAQ activity group,48064,-0.058027898789341,0.0203137505915972,-0.0978428499488716,-0.0182129476298104,0.00428682594067739
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22033.Summed days activity,48464,-0.0121027807644806,0.00455719197882972,-0.0210348770429868,-0.00317068448597433,0.00791944860877823
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22034.Summed minutes activity,48064,-0.0100085251235062,0.00460039033468726,-0.0190252901794932,-0.000991760067519144,0.0295985421105006
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22037.MET minutes per week for walking,47359,-0.00506621406442725,0.00470910940207084,-0.0142960684924861,0.0041636403636316,0.282015903751739
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22038.MET minutes per week for moderate activity,48064,-0.00637435291479446,0.0046735246224565,-0.0155344611748092,0.00278575534522029,0.172605876535052
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22039.MET minutes per week for vigorous activity,48064,-0.0847159430553536,0.0204140228487752,-0.124727427838953,-0.0447044582717541,3.34049190252158e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X22040.Summed MET minutes per week for all activity,47359,-0.00889517408423753,0.00466844615422933,-0.018045328546527,0.00025498037805196,0.0567456840485813
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X2217.Age started wearing glasses or contact lenses,48133,0.0112071067827675,0.00480705980282381,0.0017852695692328,0.0206289439963021,0.0197431886419712
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X22501.Year ended full time education,34098,-0.0657376347308706,0.0208573451824419,-0.106618031288457,-0.0248572381732845,0.00163154060224861
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X22506.Tobacco smoking,34061,-0.159919195614683,0.0746546693704214,-0.306242347580709,-0.0135960436486567,0.032228010054684
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50429,-0.0341241519968636,0.0578565780175453,-0.147523044911252,0.0792747409175251,0.555326880897724
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23098.Weight,51352,-0.0051784066117845,0.011326398248628,-0.0273781471790953,0.0170213339555264,0.647533101944622
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23099.Body fat percentage,51322,-0.00189303745541679,0.0101013169025165,-0.0216916185843492,0.0179055436735156,0.8513447634149
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23100.Whole body fat mass,51279,0.000470660201074332,0.0101034830026059,-0.0193321664840333,0.0202734868861819,0.962845230089382
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23101.Whole body fat-free mass,51346,0.00180996646690085,0.00976715148474844,-0.0173336504432061,0.0209535833770078,0.852986292568158
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23102.Whole body water mass,51352,0.000593887425681024,0.00974148759066733,-0.0184994282520269,0.019687203103389,0.951387811986676
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23104.Body mass index (BMI),51352,-0.142376067096396,0.0230142722276778,-0.187484040662644,-0.0972680935301472,6.25933996487689e-10
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23105.Basal metabolic rate,51352,0.00167069513438204,0.0101500375604232,-0.0182233784840474,0.0215647687528115,0.869260374720287
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23106.Impedance of whole body,51352,0.0203314676885698,0.00800930654506071,0.00463322686025082,0.0360297085168888,0.011140111013999
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23107.Impedance of leg (right),51352,0.00814155409396294,0.00646458051484285,-0.00452902371512904,0.0208121319030549,0.207895380576154
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23108.Impedance of leg (left),51352,0.00768473725770719,0.00644597475765224,-0.00494937326729121,0.0203188477827056,0.23320462395093
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23109.Impedance of arm (right),51352,0.0248477560051505,0.0079245910440052,0.00931555755890026,0.0403799544514006,0.00171764946750926
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23110.Impedance of arm (left),51352,0.0175400404201459,0.00792125952852789,0.00201437174423126,0.0330657090960606,0.0268180623184673
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23111.Leg fat percentage (right),51352,-0.0316093525389342,0.0102900685042255,-0.0517778868072162,-0.0114408182706522,0.00213001197081922
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23112.Leg fat mass (right),51352,-0.0105605872150378,0.0110885049873574,-0.0322940569902584,0.0111728825601828,0.340909074465828
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23113.Leg fat-free mass (right),51351,0.0126300349164937,0.0107303855740722,-0.00840152080868778,0.0336615906416753,0.239194016700463
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23114.Leg predicted mass (right),51351,0.0123395467231968,0.0108095716489938,-0.00884721370883109,0.0335263071552247,0.253657740974105
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23115.Leg fat percentage (left),51351,-0.037239726326008,0.0107709613623472,-0.0583508105962085,-0.0161286420558075,0.000546372865787217
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23116.Leg fat mass (left),51351,-0.01465464207761,0.0117417918974814,-0.0376685541966736,0.00835927004145367,0.212016276260042
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23117.Leg fat-free mass (left),51350,0.0153680260423285,0.0116756426775199,-0.0075162336056105,0.0382522856902674,0.188104518143302
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23118.Leg predicted mass (left),51350,0.0170581702440352,0.0117693000416057,-0.00600965783751192,0.0401259983255823,0.147245698162784
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23119.Arm fat percentage (right),51350,-0.00758859666021079,0.011334672263726,-0.0298045542971137,0.0146273609766921,0.503181485963536
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23120.Arm fat mass (right),51349,-0.012552334601663,0.0123900557530888,-0.0368368438777171,0.0117321746743911,0.311024363508542
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23121.Arm fat-free mass (right),51348,-0.00113741761387684,0.0107279463835726,-0.0221641925256792,0.0198893572979255,0.915564405877723
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23122.Arm predicted mass (right),51348,-0.00379436092642377,0.0107763721820129,-0.024916050403169,0.0173273285503215,0.724766510466527
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23123.Arm fat percentage (left),51346,-0.0103999482359581,0.0106877340091711,-0.0313479068939336,0.0105480104220173,0.330527237639778
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23124.Arm fat mass (left),51346,-0.0197454286338366,0.011920405230216,-0.04310942288506,0.00361856561738667,0.0976466648533876
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23125.Arm fat-free mass (left),51342,0.00276930055358168,0.00977682605650256,-0.0163932785171633,0.0219318796243267,0.776986638202751
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23126.Arm predicted mass (left),51341,0.00184716180338317,0.00982773550674309,-0.0174151997898333,0.0211095233965996,0.850914419677005
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23127.Trunk fat percentage,51340,0.00444627028853774,0.00856072717358945,-0.0123327549716976,0.0212252955487731,0.603500845926164
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23128.Trunk fat mass,51340,0.000392763595996236,0.00902949707811309,-0.0173050506771054,0.0180905778690979,0.965305070289002
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23129.Trunk fat-free mass,51339,-0.00412646885270596,0.00846839850496278,-0.020724529922433,0.0124715922170211,0.626065651352264
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X23130.Trunk predicted mass,51337,-0.00474753691259349,0.00846115307034849,-0.0213313969304765,0.0118363231052896,0.574736192778924
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23400.Total Cholesterol,41913,-0.0584403260077051,0.00598384243929013,-0.0701686571887137,-0.0467119948266964,1.86760681281773e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,41913,-0.0512774504944728,0.00585172787535182,-0.0627468371301624,-0.0398080638587832,2.1330061820172e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",41913,-0.0366342221607801,0.00589350628407322,-0.0481854944775636,-0.0250829498439966,5.25106198320621e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23403.VLDL Cholesterol,41913,-0.0190634231484119,0.00608732622499387,-0.0309945825493999,-0.00713226374742387,0.00174198772889463
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23404.Clinical LDL Cholesterol,41913,-0.0623014314655484,0.00583211410668009,-0.0737323751146413,-0.0508704878164554,1.57455153123643e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23405.LDL Cholesterol,41913,-0.0620576226927751,0.00580481357402031,-0.0734350572978549,-0.0506801880876953,1.4418341596271e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23406.HDL Cholesterol,41913,-0.0504312528514894,0.00663263182472911,-0.0634312112279584,-0.0374312944750203,3.07489417418031e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23407.Total Triglycerides,41913,0.0098091832540619,0.0061883852210277,-0.00232005177915239,0.0219384182872762,0.112968327130105
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23408.Triglycerides in VLDL,41913,0.00686189219411691,0.00628277515211124,-0.00545234710402112,0.0191761314922549,0.274775795846513
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23409.Triglycerides in LDL,41913,0.00592188566337958,0.00582603177942907,-0.00549713662430139,0.0173409079510606,0.309432338157857
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23410.Triglycerides in HDL,41913,0.0272885358308379,0.00605206104373433,0.0154264961851186,0.0391505754765572,6.57007593930657e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,41913,-0.0395539418535528,0.00602499715840986,-0.0513629362840362,-0.0277449474230695,5.39719999852093e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23412.Phospholipids in VLDL,41913,-0.00667906994236655,0.00615476221787393,-0.0187424038893995,0.00538426400466636,0.277858347313399
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23413.Phospholipids in LDL,41913,-0.0608385435521594,0.00582549509761348,-0.0722565139434818,-0.049420573160837,1.96757178880038e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23414.Phospholipids in HDL,41913,-0.0230208964629511,0.00636446732484771,-0.0354952524196526,-0.0105465405062496,0.000299027517684575
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23415.Total Esterified Cholesterol,41913,-0.0616361546726389,0.00601310629630636,-0.0734218430133994,-0.0498504663318784,1.45562123123683e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,41913,-0.0226372463746108,0.00605173461455229,-0.0344986462191333,-0.0107758465300883,0.000184336336331712
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23417.Cholesteryl Esters in LDL,41913,-0.0597032403506807,0.0058053282472451,-0.0710816837152811,-0.0483247969860803,1.0271236012649e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23418.Cholesteryl Esters in HDL,41913,-0.0542057074445531,0.00663590839906913,-0.0672120879067286,-0.0411993269823777,3.40102042128149e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23419.Total Free Cholesterol,41913,-0.0497943058569748,0.00591688325651815,-0.0613913970397504,-0.0381972146741992,4.30373792327539e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23420.Free Cholesterol in VLDL,41913,-0.0139256296776228,0.00613021663132428,-0.0259408542750184,-0.0019104050802272,0.0231243038470977
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23421.Free Cholesterol in LDL,41913,-0.066536970704638,0.00583171205846253,-0.0779671263392245,-0.0551068150700514,5.16724375466916e-30
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23422.Free Cholesterol in HDL,41913,-0.0334011252850722,0.00660270230914628,-0.0463424218109989,-0.0204598287591455,4.27733318399295e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,41913,-0.0381403736981488,0.00579141031782715,-0.04949153792109,-0.0267892094752076,4.69809710625265e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23424.Total Lipids in VLDL,41913,-0.00254663560510798,0.00616125892379848,-0.014622703095753,0.00952943188553705,0.679371218473825
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23425.Total Lipids in LDL,41913,-0.0590968119271098,0.00580719152709392,-0.0704789073202139,-0.0477147165340057,3.09722189957898e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23426.Total Lipids in HDL,41913,-0.0322434819478676,0.00646508914453948,-0.044915056671165,-0.0195719072245702,6.19934391849613e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,41913,-0.0626339857893873,0.00611299955126125,-0.0746154649098593,-0.0506525066689152,1.52083536464472e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23428.Concentration of VLDL Particles,41913,-0.0122684113763043,0.00607410678319582,-0.0241736606713681,-0.000363162081240454,0.0434253181207844
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23429.Concentration of LDL Particles,41913,-0.0466560416243685,0.00584745040045598,-0.0581170444092622,-0.0351950388394748,1.5969769627608e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23430.Concentration of HDL Particles,41913,-0.0589315256655546,0.00612168226959954,-0.0709300229139697,-0.0469330284171395,7.26776850253583e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23431.Average Diameter for VLDL Particles,41913,0.00115629660246601,0.00637893422855455,-0.0113464144855009,0.0136590076904329,0.856159987510382
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23432.Average Diameter for LDL Particles,41913,-0.0302382218076947,0.00604244250122256,-0.0420814091100909,-0.0183950345052985,5.67799606590216e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23433.Average Diameter for HDL Particles,41913,0.0146810388851118,0.00666129443217591,0.001624901798047,0.0277371759721766,0.0275461903527161
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23434.Phosphoglycerides,41905,-0.0307246344614943,0.00604302066452677,-0.0425689549639667,-0.0188803139590218,3.7396387602942e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,41905,0.0304868471616612,0.00652793037189214,0.0176921036327526,0.0432815906905698,3.03825840746525e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23436.Total Cholines,41905,-0.0382547302892058,0.00614267149422856,-0.0502943664178938,-0.0262150941605178,4.87568747566223e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23437.Phosphatidylcholines,41905,-0.0336355939838395,0.00616962485281988,-0.0457280586953664,-0.0215431292723125,5.07501569407079e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23438.Sphingomyelins,41905,-0.054218444232613,0.00619365395987236,-0.0663580059939628,-0.0420788824712631,2.30767924202641e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23439.Apolipoprotein B,41913,-0.0424625847377632,0.00586933573455477,-0.0539664827774906,-0.0309586866980359,4.92263909777183e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23440.Apolipoprotein A1,41913,-0.0399584423860983,0.00632147258516069,-0.0523485286530132,-0.0275683561191833,2.68052568790262e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,41913,-0.0182396382737342,0.00601006999644933,-0.0300193754667749,-0.00645990108069355,0.00241122883930521
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23442.Total Fatty Acids,41905,-0.0138981761844978,0.00565040684169341,-0.0249729735942169,-0.00282337877477876,0.0139188336097078
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23443.Degree of Unsaturation,41905,-0.0530456684731338,0.00612220985249018,-0.0650451997840145,-0.041046137162253,5.05528870814993e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23444.Omega-3 Fatty Acids,41905,-0.0371675665315017,0.00594079850866815,-0.0488115316084913,-0.0255236014545121,4.06233445105324e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23445.Omega-6 Fatty Acids,41905,-0.0348900729802735,0.00584176188736731,-0.0463399262795134,-0.0234402196810336,2.39567558132746e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,41905,-0.0391377499743999,0.00586620088213633,-0.0506355037033871,-0.0276399962454127,2.62794343374444e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23447.Monounsaturated Fatty Acids,41905,0.00496387641773569,0.0057575197602629,-0.0063208623123796,0.016248615147851,0.388617579274243
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23448.Saturated Fatty Acids,41905,-0.0099089549738771,0.00558086074827234,-0.0208474420404909,0.00102953209273669,0.0758341775993847
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23449.Linoleic Acid,41905,-0.0246428644952245,0.00583731654219571,-0.0360840049179281,-0.0132017240725209,2.44176186338404e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23450.Docosahexaenoic Acid,41905,-0.0494425161353954,0.0058952984337669,-0.0609973010655785,-0.0378877312052122,5.49615734904337e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,41905,-0.0371194377307846,0.00596456353770542,-0.0488099822646872,-0.025428893196882,5.01323240418328e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,41905,-0.0212072698069664,0.00586449461511081,-0.0327016792525835,-0.00971286036134918,0.000300048218435201
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,41905,-0.0347992504718348,0.00600075153434491,-0.0465607234791508,-0.0230377774645188,6.81665286390455e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,41905,0.0461732006932378,0.00628450539621437,0.0338555701166576,0.058490831269818,2.1427185786129e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,41905,0.00949254982498373,0.00546900122382487,-0.00122669257371302,0.0202117922236805,0.0826399028112044
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,41905,-0.0169011707066234,0.00601509224221604,-0.0286907515013669,-0.00511158991188,0.00496455583072483
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,41905,-0.0399568175247701,0.00584501863845228,-0.0514130540561366,-0.0285005809934036,8.49580319794041e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,41905,-0.0429769455643216,0.00623306022737742,-0.0551937436099814,-0.0307601475186619,5.62956364618197e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,41905,0.0268795250484691,0.00589278136458822,0.0153296735738762,0.038429376523062,5.12596573689346e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23460.Alanine,41910,0.0209877004781376,0.00588109503097612,0.00946075421742445,0.0325146467388508,0.000360057036818519
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23461.Glutamine,41873,-0.0101887913745758,0.00578963195715144,-0.0215364700105926,0.00115888726144105,0.0784589829236733
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23462.Glycine,41899,0.00733216010209195,0.0070075956651387,-0.00640272740157989,0.0210670476057638,0.295434135057028
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23463.Histidine,41897,-0.0163702238188984,0.00582547005916067,-0.0277881451348533,-0.00495230250294348,0.00495966062092723
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),41903,0.00414084694215426,0.00653362772867601,-0.00866506340605071,0.0169467572903592,0.526238864027641
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23465.Isoleucine,41911,0.00548275964367229,0.00630700400336582,-0.00687896820292471,0.0178444874902693,0.384691709042585
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23466.Leucine,41911,-0.00439231581205918,0.00648149594202492,-0.017096047858428,0.00831141623430967,0.497992685546741
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23467.Valine,41903,0.00796200441515225,0.00648912278068996,-0.00475667623500006,0.0206806850653046,0.219852948850529
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23468.Phenylalanine,41906,0.0258621627624398,0.00600067823703051,0.01410083341786,0.0376234921070196,1.64522070823091e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23469.Tyrosine,41899,0.0170933841704577,0.00621640386201862,0.00490923260090125,0.0292775357400142,0.00597263625531147
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23470.Glucose,41892,0.0330784843635677,0.00566240300422771,0.0219801744752814,0.044176794251854,5.28562569887435e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23471.Lactate,41892,0.0112532514249887,0.00598223475031197,-0.000471928685622756,0.0229784315356002,0.0599785731569689
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23472.Pyruvate,41871,0.010870900563518,0.0057400319183976,-0.000379561996541324,0.0221213631235773,0.0582633850942039
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23473.Citrate,41911,0.0243791904424693,0.00592249263298781,0.0127711048818132,0.0359872760031254,3.87201403598702e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23474.3-Hydroxybutyrate,41634,0.000524021183495429,0.00655305249849995,-0.0123199617135645,0.0133680040805553,0.936265550889855
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23475.Acetate,41901,-0.0187172051416562,0.00565785387530685,-0.0298065987372577,-0.00762781154605481,0.000941533062450131
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23476.Acetoacetate,41912,-0.00614945362602615,0.00593607511250271,-0.0177841608465315,0.00548525359447916,0.300246125189638
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23477.Acetone,41912,-0.0175617043231731,0.00590312016668336,-0.0291318198498724,-0.00599158879647367,0.00293527110734762
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23478.Creatinine,41656,0.0371005347906977,0.00710435600325994,0.0231759970243082,0.0510250725570872,1.79504116478095e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23479.Albumin,41911,-0.0644829648477538,0.00586382622040461,-0.0759760642397469,-0.0529898654557608,5.22921794148711e-28
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23480.Glycoprotein Acetyls,41913,0.0401472017265972,0.00610621283960716,0.0281790245609671,0.0521153788922272,5.05316836438722e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,41913,0.0254762867801505,0.00622445430545126,0.013276356341466,0.037676217218835,4.28459854504351e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,41913,0.0262258326165255,0.00618875974334651,0.0140958635195663,0.0383558017134847,2.27386818953093e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,41913,0.0275803770932324,0.00639284936003086,0.0150503923475719,0.0401103618388928,1.61297389686015e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,41913,0.0246627543752308,0.00629191344802269,0.0123306040171063,0.0369949047333552,8.90830969571957e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,41913,0.0244138388440602,0.00629256484817041,0.0120804117416462,0.0367472659464742,0.000105049616677982
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,41913,0.0240080363367552,0.00624583921452125,0.0117661914762935,0.0362498811972168,0.000121684833882889
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,41913,0.0268078810515524,0.006067137503885,0.0149162915439378,0.038699470559167,1.00155710020126e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,41913,0.00774589973653229,0.00648788559068958,-0.00497035602121929,0.0204621554942839,0.232537568658244
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,41913,0.00811972661974988,0.00644222522075339,-0.00450703481292676,0.0207464880524265,0.207550217235954
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,41913,0.00916871924752012,0.00643935225715188,-0.00345241117649757,0.0217898496715378,0.15451119724803
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,41913,-0.000971248600199807,0.00640175984155987,-0.0135186978896571,0.0115762006892575,0.879413334028973
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,41913,-0.00896681260043078,0.00639313321583399,-0.0214973537034654,0.00356372850260384,0.160768619753672
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,41913,0.00684339043128529,0.00638570318131344,-0.00567258780408906,0.0193593686666596,0.283886024961287
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,41913,0.0103414308864836,0.00645790010785577,-0.00231605332491372,0.0229989150978809,0.109320659804081
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23495.Concentration of Large VLDL Particles,41913,1.91976613427177e-05,0.00639196778214515,-0.0125090591916618,0.0125474545143472,0.997603678954305
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23496.Total Lipids in Large VLDL,41913,-0.00324526488201954,0.00637429428434031,-0.0157388816793266,0.00924835191528747,0.610678291513669
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23497.Phospholipids in Large VLDL,41913,0.00194835197767709,0.00649848509408475,-0.010788678806729,0.0146853827620832,0.764321936185886
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23498.Cholesterol in Large VLDL,41913,-0.00864529925507913,0.00642333519079483,-0.021235036229037,0.00394443771887874,0.178351038199366
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,41913,-0.0141851786871144,0.00637681884258409,-0.0266837436185792,-0.00168661375564956,0.0261321015153278
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,41913,-0.00370485229280227,0.00648111733137247,-0.0164078422622923,0.00899813767668777,0.567576965112418
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23501.Triglycerides in Large VLDL,41913,-0.00354133267114351,0.00628433679594182,-0.0158586327911895,0.00877596744890245,0.573092156123502
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,41913,-0.0323560024278219,0.00601399378672117,-0.0441434302497954,-0.0205685746058484,7.569635776034e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23503.Total Lipids in Medium VLDL,41913,-0.0266888007131571,0.00603370391511402,-0.0385148603867806,-0.0148627410395336,9.7981982521645e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23504.Phospholipids in Medium VLDL,41913,-0.0321174494558757,0.00599840485465236,-0.0438743229709944,-0.0203605759407571,8.72994984206114e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23505.Cholesterol in Medium VLDL,41913,-0.0441970262439326,0.00588450798458276,-0.0557306618937148,-0.0326633905941504,6.25337555561323e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,41913,-0.0473701598778965,0.00586522255823763,-0.0588659960920422,-0.0358743236637507,7.23841772316688e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,41913,-0.0369513448985608,0.00596466706345128,-0.0486420923429253,-0.0252605974541963,5.99869998924359e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23508.Triglycerides in Medium VLDL,41913,-0.011032197772028,0.0062023707295384,-0.0231888444019233,0.00112444885786726,0.0753106894639753
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23509.Concentration of Small VLDL Particles,41913,-0.0114319797408218,0.0062134745434296,-0.0236103898459438,0.000746430364300237,0.0658097082032952
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23510.Total Lipids in Small VLDL,41913,-0.015143975483729,0.00621756114850191,-0.0273303953347927,-0.00295755563266521,0.0148769490697249
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23511.Phospholipids in Small VLDL,41913,-0.0302481247612011,0.00608945646657607,-0.0421834594356902,-0.018312790086712,6.87356963302841e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23512.Cholesterol in Small VLDL,41913,-0.0305319263051982,0.0061416867462252,-0.0425696323277996,-0.0184942202825968,6.73467355675472e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,41913,-0.0246827501466752,0.00625386416797047,-0.0369403239158973,-0.0124251763774531,7.96097122652417e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,41913,-0.0395548314913722,0.00596897748370679,-0.0512540273594375,-0.0278556356233069,3.56401332071088e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23515.Triglycerides in Small VLDL,41913,0.00821961813438511,0.00627349291871027,-0.00407642798628703,0.0205156642550572,0.190146062241552
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,41913,-0.00535109232420292,0.00594460771954272,-0.0170025234545066,0.0063003388061008,0.368051907316595
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,41913,-0.00266307467432682,0.00598830924670773,-0.014400160797874,0.00907401144922033,0.656534921338945
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,41913,0.00456942462662381,0.00597021693962122,-0.00713220057503379,0.0162710498282814,0.444064850851177
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,41913,-0.0177667862369343,0.00601898988737861,-0.0295640064161964,-0.00596956605767222,0.00316490158330164
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,41913,-0.0219926167814428,0.0060584761832269,-0.0338672301005675,-0.0101180034623181,0.00028442036683445
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,41913,-0.00755738121792642,0.00597413876756942,-0.0192666932023625,0.00415193076650965,0.205887728879
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,41913,0.0220117652519807,0.00609103580647159,0.0100733350712964,0.033950195432665,0.000302857965477132
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23523.Concentration of IDL Particles,41913,-0.0368643100401303,0.0058766410408355,-0.0483825264801679,-0.0253460936000928,3.65062138776765e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23524.Total Lipids in IDL,41913,-0.0462319398166686,0.00599974217143711,-0.0579914344726853,-0.0344724451606519,1.39364748147915e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23525.Phospholipids in IDL,41913,-0.0410015347019711,0.00599924245835847,-0.0527600499203537,-0.0292430194835885,8.59025749279158e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23526.Cholesterol in IDL,41913,-0.0524879146248443,0.00602720171727438,-0.0643012299907021,-0.0406745992589866,3.43856484291489e-18
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23527.Cholesteryl Esters in IDL,41913,-0.0533983081656946,0.00603451782515389,-0.0652259631029962,-0.041570653228393,9.94954001101239e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23528.Free Cholesterol in IDL,41913,-0.0484388892174769,0.00598715721920107,-0.060173717367111,-0.0367040610678428,6.45569359449995e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23529.Triglycerides in IDL,41913,0.0180894484850257,0.00588484319769773,0.00655515581753816,0.0296237411525132,0.00211704123991928
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23530.Concentration of Large LDL Particles,41913,-0.0478439997965864,0.00582102487861034,-0.0592532085586627,-0.0364347910345101,2.2374715951928e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23531.Total Lipids in Large LDL,41913,-0.0607518035205426,0.0058338252977305,-0.0721861011040944,-0.0493175059369908,2.68488805875543e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23532.Phospholipids in Large LDL,41913,-0.0614079277843878,0.00585092963219887,-0.0728757498634976,-0.049940105705278,1.14210309732478e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23533.Cholesterol in Large LDL,41913,-0.0637925585907526,0.00583505026301393,-0.0752292571062599,-0.0523558600752453,1.05523702772409e-27
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,41913,-0.062793546864165,0.00582715095625062,-0.0742147627384162,-0.0513723309899137,5.77149961280917e-27
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23535.Free Cholesterol in Large LDL,41913,-0.0653227337595143,0.00588374357454521,-0.076854871165623,-0.0537905963534057,1.63193578608841e-28
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23536.Triglycerides in Large LDL,41913,0.00598777027753804,0.00581648337489798,-0.00541253713726199,0.0173880776923381,0.303287655104514
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23537.Concentration of Medium LDL Particles,41913,-0.0447683633635915,0.00588604494460473,-0.0563050114550167,-0.0332317152721662,3.01993949196748e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23538.Total Lipids in Medium LDL,41913,-0.0567269211150075,0.00583803149862882,-0.0681694628523199,-0.045284379377695,3.03142850758464e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23539.Phospholipids in Medium LDL,41913,-0.0598530919158,0.00585859475328392,-0.0713359376322365,-0.0483702461993635,2.06272148162876e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23540.Cholesterol in Medium LDL,41913,-0.058865993360034,0.00582875220253315,-0.070290347676999,-0.047441639043069,6.78697511443511e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,41913,-0.0540300188091857,0.00585403196950338,-0.0655039214694124,-0.0425561161489591,3.12285513280054e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,41913,-0.0684670965545812,0.00579437796169973,-0.0798240773595127,-0.0571101157496497,4.65875383884666e-32
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23543.Triglycerides in Medium LDL,41913,0.00308253535718077,0.00585778899541248,-0.0083987310738277,0.0145638017881892,0.598738239349147
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23544.Concentration of Small LDL Particles,41913,-0.0374080335038772,0.00589610348192193,-0.0489643963284442,-0.0258516706793102,2.30320962611258e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23545.Total Lipids in Small LDL,41913,-0.0518479339928243,0.00580225265883745,-0.0632203492041457,-0.0404755187815029,4.56680893149166e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23546.Phospholipids in Small LDL,41913,-0.0537402254068339,0.00578440898442041,-0.0650776670162979,-0.0424027837973699,1.7703688646609e-20
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23547.Cholesterol in Small LDL,41913,-0.0552932771273521,0.00581701685042025,-0.0666946301541758,-0.0438919241005284,2.3284042625378e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,41913,-0.0491675521035654,0.00582274161568568,-0.0605801256703093,-0.0377549785368215,3.38000884910536e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23549.Free Cholesterol in Small LDL,41913,-0.0652741819382623,0.00580952289436647,-0.0766608468112205,-0.053887517065304,3.68283887112729e-29
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23550.Triglycerides in Small LDL,41913,0.0106297056267226,0.00593484171451569,-0.00100258413372816,0.0222619953871733,0.0733050775722844
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,41913,0.00497150242901856,0.00677595411010674,-0.00830936762679065,0.0182523724848278,0.463145877254819
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23552.Total Lipids in Very Large HDL,41913,0.0130756448714757,0.00679737115076905,-0.000247202584031624,0.0263984923269831,0.0544219476093885
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23553.Phospholipids in Very Large HDL,41913,0.0227564433667179,0.00676273389871536,0.00950148492523577,0.0360114018082,0.000767662922493032
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23554.Cholesterol in Very Large HDL,41913,-0.00337578143491552,0.00687376975201353,-0.016848370148862,0.010096807279031,0.623356294754279
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,41913,-0.00969054396601353,0.00690920358479066,-0.0232325829922032,0.00385149506017617,0.16077264066186
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,41913,0.0173839474158596,0.00668029541140836,0.00429056840949925,0.03047732642222,0.00927108892371161
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23557.Triglycerides in Very Large HDL,41913,0.0271851934289182,0.00567036263436331,0.0160712826655661,0.0382991041922703,1.65042337307918e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23558.Concentration of Large HDL Particles,41913,-0.0166187526091128,0.00683761990162582,-0.0300204876162994,-0.0032170176019262,0.0150916281588849
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23559.Total Lipids in Large HDL,41913,-0.0104538398052749,0.00678318117999093,-0.0237488749180571,0.00284119530750734,0.123306198172685
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23560.Phospholipids in Large HDL,41913,-0.00522867388040243,0.00671937478566628,-0.0183986484603083,0.00794130069950348,0.436495085638345
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23561.Cholesterol in Large HDL,41913,-0.0212772572014859,0.00687926991790278,-0.0347606262405753,-0.0077938881623964,0.00198585703816265
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,41913,-0.0252845902751972,0.00690215555101235,-0.0388128151551814,-0.011756365395213,0.000249963288297754
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23563.Free Cholesterol in Large HDL,41913,-0.00745634906683991,0.00680154480543733,-0.0207873768854971,0.00587467875181726,0.272979206986573
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23564.Triglycerides in Large HDL,41913,0.0359698440799315,0.00596518164394255,0.0242780880578041,0.0476616001020589,1.68335582543275e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23565.Concentration of Medium HDL Particles,41913,-0.0362244563123375,0.0062560903180524,-0.0484863933357202,-0.0239625192889548,7.1858906622555e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23566.Total Lipids in Medium HDL,41913,-0.0315653901777591,0.00615384114106211,-0.0436269188142408,-0.0195038615412774,2.94783047464543e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23567.Phospholipids in Medium HDL,41913,-0.0237404572921317,0.00605200009289692,-0.0356023774742097,-0.0118785371100537,8.79851191869607e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23568.Cholesterol in Medium HDL,41913,-0.0459439636592165,0.00632485460486623,-0.0583406786847543,-0.0335472486336787,3.96600689818487e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,41913,-0.0476268195706403,0.00631548950809212,-0.0600051790065008,-0.0352484601347797,4.95516486432257e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,41913,-0.0373180964838774,0.00635732550972948,-0.0497784544829472,-0.0248577384848076,4.45921438943353e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23571.Triglycerides in Medium HDL,41913,0.0267541890580683,0.00611749725701463,0.0147638944343197,0.038744483681817,1.23262324544729e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23572.Concentration of Small HDL Particles,41913,-0.0720598477572092,0.00582557667366225,-0.0834779780375872,-0.0606417174768312,5.9413151309788e-35
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23573.Total Lipids in Small HDL,41913,-0.0525525541396227,0.00583438292120779,-0.0639879446651899,-0.0411171636140554,2.39389399407489e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23574.Phospholipids in Small HDL,41913,-0.0424112083074713,0.00580992120704919,-0.0537986538732877,-0.0310237627416549,3.04560842634263e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23575.Cholesterol in Small HDL,41913,-0.0740403357635333,0.00579586315697594,-0.0854002275512062,-0.0626804439758605,3.75158691449839e-37
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,41913,-0.0783290976597095,0.00582711523491541,-0.0897502435201437,-0.0669079517992753,6.32597459062028e-41
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23577.Free Cholesterol in Small HDL,41913,-0.0523319132369419,0.00579478917223397,-0.0636897000145205,-0.0409741264593634,1.93482134616492e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23578.Triglycerides in Small HDL,41913,0.0180702140798201,0.00658468740607162,0.00516422676391974,0.0309762013957205,0.006072537017838
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41534,0.000511685258172794,0.00660648234477257,-0.0124370201375814,0.013460390653927,0.938265174492687
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41534,-0.015778565348902,0.00633802206511829,-0.0282010885965338,-0.00335604210127012,0.0128044205095705
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41534,-0.0147639091527697,0.00641908485658167,-0.0273453154716698,-0.00218250283386965,0.021463940617556
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41534,-0.0168961260340952,0.00634159948500618,-0.0293256610247073,-0.0044665910434831,0.00772370797717367
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41534,0.0129828210620039,0.0064163338247866,0.000406806765422152,0.0255588353585856,0.0430522694480484
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,41842,0.0081585821247829,0.00647009078886886,-0.00452279582140007,0.0208399600709659,0.207342331289749
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,41842,-0.0269930263162586,0.00653080100038087,-0.0397933962770051,-0.0141926563555121,3.59968635942522e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,41842,-0.029793653716335,0.00648946430727027,-0.0425130037585847,-0.0170743036740853,4.45014936466532e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,41842,-0.00752626704504625,0.0065539766070248,-0.0203720611948149,0.00531952710472235,0.250844345218969
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,41842,0.0213952602470729,0.006510715524715,0.00863425781863148,0.0341562626755143,0.0010182704648353
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,41913,0.0321549380625259,0.00675911039328996,0.0189070816916776,0.0454027944333742,1.9828492706952e-06
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,41913,-0.0168203005081015,0.00631956956434777,-0.0292066568542231,-0.00443394416197983,0.00778586966996263
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,41913,-0.0192085002840836,0.00641845312000022,-0.031788668399284,-0.00662833216888315,0.00277029200064607
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,41913,-0.0044664723956476,0.00641486013884696,-0.0170395982677877,0.00810665347649244,0.486272134373622
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,41913,0.00413458322977104,0.00644388176482272,-0.00849542502928149,0.0167645914888236,0.521124962244059
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,41913,-0.0303649568610761,0.00618537425730471,-0.0424882904053933,-0.0182416233167589,9.25542077711857e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,41913,-0.0352781845163467,0.00640502013539416,-0.0478320239817192,-0.0227243450509741,3.69884129380795e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,41913,-0.0351741046567185,0.00644721381269219,-0.0478106437295952,-0.0225375655838419,4.96503313076471e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,41913,-0.0346568419073689,0.0062631597600918,-0.0469326350371488,-0.022381048777589,3.19934843359596e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,41913,0.0342578926979397,0.00634919285251025,0.0218134747070196,0.0467023106888598,6.94523781004838e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,41913,-0.0559149534451861,0.00623431731054551,-0.0681342153738553,-0.0436956915165169,3.39042023820667e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,41913,-0.0391502896584564,0.00602809386670453,-0.0509653536371973,-0.0273352256797155,8.61897489581922e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,41913,-0.0251461511311698,0.00594561460187075,-0.0367995557508365,-0.0134927465115031,2.35922309801272e-05
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,41913,-0.0559332352301922,0.00628678034373263,-0.0682553247039082,-0.0436111457564762,6.47242190900826e-19
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,41913,0.0445504434272609,0.00608594529493583,0.0326219906491867,0.0564788962053352,2.61768298171124e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,41913,0.0567681692667177,0.00590341108350749,0.045197483543043,0.0683388549903924,8.04515648037872e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,41913,-0.0439260024520405,0.00622438846178498,-0.056125803837139,-0.0317262010669419,1.78455131269754e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,41913,-0.0446435908399769,0.00630928956866651,-0.0570097983945633,-0.0322773832853905,1.55965624112523e-12
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,41913,-0.0304958244187789,0.00550814165306111,-0.0412917820587786,-0.0196998667787791,3.14417558652271e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,41913,0.0353885409368728,0.00615041336869404,0.0233337307342325,0.0474433511395131,8.91552128794358e-09
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,41913,0.0494254644227475,0.0057781695758903,0.0381002520540025,0.0607506767914924,1.31976826722569e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,41913,-0.0644139436372883,0.00604599205580541,-0.0762640880666669,-0.0525637992079097,2.13380532868372e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,41913,-0.0629001021802278,0.00596411799043449,-0.0745897734414794,-0.0512104309189762,6.67593853094247e-26
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,41913,-0.0279351319100548,0.00556583788805597,-0.0388441741706445,-0.0170260896494651,5.26025502195472e-07
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,41913,0.062053524417343,0.00608699168314692,0.0501230207183751,0.073984028116311,2.57863334277098e-24
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,41913,0.0126069835655109,0.00592989999183999,0.000984379581504487,0.0242295875495173,0.0335213826281721
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,41913,-0.0795123678782526,0.00600758263491215,-0.0912872298426804,-0.0677375059138248,9.77474209362435e-40
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,41913,-0.0593930013131602,0.00575536318883115,-0.0706735131632692,-0.0481124894630511,7.13081543756756e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,41913,-0.0473753907320065,0.00645991164759665,-0.060036817561296,-0.0347139639027171,2.36728438601746e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,41913,0.0710427046186545,0.00592008054085305,0.0594393467585826,0.0826460624787265,5.23958740046923e-33
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,41913,-0.00581605202416412,0.00609901934217018,-0.0177701299348177,0.00613802588648943,0.340301212751508
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,41913,-0.0626645048839161,0.00599409964320624,-0.0744129401846003,-0.0509160695832319,1.75620979487435e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,41913,-0.0104312269044475,0.00608605517944831,-0.0223598950561662,0.00149744124727119,0.0865602019445076
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,41913,-0.0454723135242166,0.00624815701391273,-0.0577187012714855,-0.0332259257769476,3.58539316364562e-13
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,41913,0.070163562426042,0.00590504171075915,0.0585896806729541,0.0817374441791299,2.14085153049376e-32
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,41913,0.00800445789060933,0.00605606325147812,-0.00386542608228778,0.0198743418635064,0.186282029014934
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,41913,-0.0559514324436398,0.00589149963666221,-0.0674987717314978,-0.0444040931557819,2.52408298400393e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,41913,-0.0118605265260324,0.00600382905704765,-0.0236280314778458,-9.30215742189888e-05,0.0482327677347374
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,41913,-0.0475349784276961,0.00594057263417033,-0.05917850079067,-0.0358914560647223,1.32762497534705e-15
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,41913,0.0588527901359651,0.00603887812149941,0.0470165890178262,0.0706889912541039,2.28710066978256e-22
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,41901,0.0492540466201747,0.00644466014573408,0.0366225127345359,0.0618855805058135,2.27404091359098e-14
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,41901,-0.0583703157512897,0.00560177876002768,-0.0693498021209439,-0.0473908293816354,2.51616610302736e-25
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,41901,-0.0706687984346214,0.00520153649311719,-0.0808638099611311,-0.0604737869081117,9.19068856910005e-42
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,41901,-0.00246047928067964,0.00669350568155937,-0.015579750416536,0.0106587918551767,0.713183313958058
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,41901,0.0114113118086657,0.00629250432877365,-0.000921996675730626,0.0237446202930621,0.0697808115428625
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,41913,0.0336550918343713,0.00594698633404244,0.0219989986196481,0.0453111850490945,1.55231291231465e-08
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,41913,-0.0422268479473021,0.00626796775589909,-0.0545120647488643,-0.0299416311457398,1.68419372759036e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,41913,-0.0485537539736685,0.00603284445409277,-0.0603781291036903,-0.0367293788436467,9.10778729614534e-16
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,41913,0.00771850394248886,0.00601347261089282,-0.00406790237486107,0.0195049102598388,0.199326965995387
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,41913,0.0379986180083967,0.00602790239915266,0.0261839293060575,0.0498133067107359,2.99623818501335e-10
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,41913,0.0696719790160287,0.00642230131918236,0.0570842684304313,0.0822596896016261,2.63858805320695e-27
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,41913,-0.0635309499538705,0.00641339105881003,-0.0761011964291382,-0.0509607034786029,4.71107967710641e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,41913,-0.0576404019592118,0.00609916865197134,-0.0695947725170757,-0.045686031401348,3.92622466147349e-21
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,41913,-0.0441566218438352,0.00669072391120347,-0.057270440709794,-0.0310428029778764,4.27654377481397e-11
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,41913,0.0537031691152034,0.00632556520273906,0.0413050613178348,0.0661012769125719,2.2861774228434e-17
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,41913,0.0589601798121559,0.00588726467027082,0.0474211410584251,0.0704992185658867,1.58846270490832e-23
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,41913,-0.0689399166818972,0.00582146678061057,-0.0803499915718939,-0.0575298417919005,3.41935973884747e-32
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,41913,-0.0663354872359613,0.00574113824120401,-0.0775881181887212,-0.0550828562832015,9.82700981367929e-31
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,41913,-0.0141018983316503,0.00624118688404897,-0.0263346246243863,-0.00186917203891436,0.0238690294686076
SLAMF1,Signaling lymphocytic activation molecule,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,41913,0.0541951088810293,0.00658460508825378,0.0412892829080519,0.0671009348540067,2.03532486887591e-16
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51550,-0.00131230589780441,0.00502279974606786,-0.0111569934000974,0.00853238160448859,0.793886796532373
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51550,0.00104048165467283,0.00487442455712517,-0.00851339047729249,0.0105943537866382,0.830972163396342
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50031,0.00168546902807661,0.00467079915982779,-0.00746929732518586,0.0108402353813391,0.718213354743994
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50031,0.00293582163126191,0.00508084067105586,-0.00702262608400756,0.0128942693465314,0.5633903563056
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50031,-0.00287352218737222,0.00503052764900433,-0.0127333563794207,0.00698631200467626,0.567858643504876
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50031,-0.00346473007452573,0.00463088103441859,-0.0125412569019862,0.0056117967529347,0.454360128239243
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24009.Traffic intensity on the nearest road,51550,-0.0311105362283095,0.0402891895010229,-0.110077347650314,0.0478562751936955,0.440015337810325
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24010.Inverse distance to the nearest road,51550,0.00129354207415457,0.00438348274195386,-0.00729808410007499,0.00988516824838412,0.767924286218074
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24011.Traffic intensity on the nearest major road,51550,0.000333867850623076,0.00437199179480916,-0.00823523606720288,0.00890297176844903,0.939129253006507
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24012.Inverse distance to the nearest major road,51550,-0.00268511745230376,0.00444075759380925,-0.0113890023361699,0.00601876743156237,0.545415553250333
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24013.Total traffic load on major roads,51550,0.00302604258794033,0.0282234285134339,-0.0522918772983902,0.0583439624742709,0.914617450048718
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24015.Sum of road length of major roads within 100m,51550,-0.00236744137847468,0.0274841960038963,-0.0562364655461114,0.051501582789162,0.931357244905241
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51550,-0.00343886215929781,0.00504064178826321,-0.0133185200642937,0.00644079574569808,0.495102280348767
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51550,-0.00231263980731668,0.00504098786253694,-0.0121929760178891,0.00756769640325572,0.646405706948054
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51550,-0.0021646819967,0.00498104180043687,-0.0119275239255563,0.00759815993215627,0.663868361600408
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51514,-0.00227410788548715,0.0048697390087096,-0.011818796342558,0.00727058057158367,0.640513167431338
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24020.Average daytime sound level of noise pollution,51550,-0.00406531907678453,0.004378104390862,-0.012646403682874,0.00451576552930499,0.353128528354455
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24021.Average evening sound level of noise pollution,51550,-0.00414950434129971,0.00437831263148927,-0.0127309970990187,0.00443198841641926,0.343271540363425
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24022.Average night-time sound level of noise pollution,51550,-0.00407197602734556,0.00437825328601771,-0.0126533524679403,0.00450940041324915,0.352357160119532
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51550,-0.00409680559939698,0.00437838803029015,-0.0126784461387657,0.00448483493997171,0.349443642022182
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51550,-0.00411884882709262,0.00437841962374088,-0.0127005512896247,0.0044628536354395,0.346860385012809
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2405.Number of children fathered,51542,0.00694582981675084,0.0212102119592178,-0.034626185623316,0.0485178452568177,0.743311078554075
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49083,-0.00173710240916519,0.00519874316383355,-0.0119266390102789,0.00845243419194856,0.738278155576972
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49083,0.00236276226684167,0.00467291504211771,-0.00679615121570904,0.0115216757493924,0.61312242399525
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24502.Water percentage, buffer 1000m",49083,0.000947490509889135,0.00471430015383653,-0.00829253779163047,0.0101875188114087,0.84071447248509
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49083,-0.00330024286629477,0.00488435161671233,-0.0128735720350509,0.00627308630246139,0.499253523367827
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49083,0.00233438686030987,0.00471724596400415,-0.00691141522913827,0.011580188949758,0.620702680929097
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24505.Water percentage, buffer 300m",49083,0.00294109650713975,0.0047433527267773,-0.00635587483734375,0.0122380678516233,0.535234452535338
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51624,0.00174236858896606,0.00498291579133812,-0.00802414636205666,0.0115088835399888,0.726590709859442
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51624,0.00209057154292544,0.00466443334269531,-0.00705171780875737,0.0112328608946082,0.654017331745068
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X24508.Distance (Euclidean) to coast,51624,0.000768306696113036,0.00441001647148847,-0.00787532558800436,0.00941193898023043,0.861695235682431
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2867.Age started smoking in former smokers,35407,-0.0156484992201454,0.00812447736184119,-0.0315724748493541,0.000275476409063322,0.0541343543068686
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36898,-0.0104172759521908,0.0412748211027636,-0.0913159253136074,0.0704813734092258,0.800747307285968
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36896,0.0133810474438925,0.0471248361173616,-0.0789836313461363,0.105745726233921,0.776456595593299
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36896,-0.00165782158020937,0.0442565320561193,-0.0884006244102032,0.0850849812497845,0.970119641079763
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36886,-0.0146469229792797,0.0443232863241664,-0.101520564174646,0.0722267182160865,0.741063329261346
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28739.Difficulty with standing for long periods,36903,0.0872285378872275,0.0379853628500862,0.0127772267010585,0.161679849073397,0.0216793921171999
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28740.Difficulty with taking care of household responsibilities,36919,0.105072272022237,0.0444525970028168,0.0179451818967156,0.192199362147758,0.0181166844090084
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28741.Difficulty learning a new task,36872,0.0474532181665915,0.0517626485058746,-0.0540015729049227,0.148908009238106,0.359302316519393
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28742.Difficulty with joining in community activities,36446,-0.053596401438665,0.0472453136868895,-0.146197216264968,0.0390044133876384,0.256649776794912
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28743.Difficulty with being emotionally affected by health problems,36866,0.0191105113490078,0.0419742574697456,-0.0631590332916935,0.101380055989709,0.648911696645105
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36925,0.0312577816436264,0.0563634968135493,-0.0792146721109303,0.141730235398183,0.579200351879761
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34810,0.0750554922173715,0.038929254637429,-0.00124584687198945,0.151356831306732,0.0539010306282041
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2897.Age stopped smoking,35402,0.0204432884641191,0.0085610999722859,0.00366353251843877,0.0372230444097995,0.0169707967689535
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35974,-0.00699183971716444,0.0174316616053142,-0.0411578964635803,0.0271742170292515,0.688358112225661
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35974,0.00688752658563513,0.0197064838734775,-0.0317371818063807,0.0455122349776509,0.72671974344009
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35974,-0.0120182764279822,0.0651230400184153,-0.139659434864076,0.115622882008112,0.853589256684354
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35974,-0.0470811871249216,0.0651109279349536,-0.174698605877431,0.0805362316275875,0.469646335543129
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35974,0.0633812015994718,0.0812325428008511,-0.0958345822901963,0.22259698548914,0.435272329896079
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35974,0.0335391095244016,0.0736559250049738,-0.110826503485347,0.17790472253415,0.648871999071121
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35974,-0.0161589965333055,0.0296684780089147,-0.0743092134307784,0.0419912203641674,0.586009338434318
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35974,0.0971047196874914,0.0561403002678902,-0.0129302688375734,0.207139708212556,0.0837294207180592
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29002.Recent lack of interest or pleasure in doing things,35931,-0.0210870513461771,0.0450057507546208,-0.109298322825234,0.0671242201328797,0.639411504088983
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29003.Recent feelings of depression,35931,-0.0389295557940561,0.0445652711777201,-0.126277487302388,0.0484183757142754,0.382397326378472
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35933,-0.00751778205934236,0.0351742338988179,-0.0764592805010255,0.0614237163823407,0.830763713042826
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29005.Recent feelings of tiredness or low energy,35935,0.0269504182005347,0.0345464030224321,-0.0407605317234323,0.0946613681245017,0.435344090856732
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29006.Recent poor appetite or overeating,35941,0.0576876499137665,0.0555013200014106,-0.0510949372889982,0.166470237116531,0.298656520771951
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29007.Recent feelings of inadequacy,35918,-0.0470997962145144,0.048720304905981,-0.142591593830237,0.0483920014012084,0.333706713307592
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29008.Recent trouble concentrating on things,35937,0.0376723098624555,0.046903963747894,-0.0542594590834167,0.129604078808328,0.421896922522546
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35935,0.0444234464760495,0.07978267149349,-0.111950589651191,0.20079748260329,0.577677179345647
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29010.Recent thoughts of suicide or self-harm,35913,0.0564676867570815,0.0873590267593898,-0.114756005691322,0.227691379205485,0.518049436016465
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#0.Substances taken for depression_None of options listed,35842,-0.0164500119794123,0.0334528960834378,-0.0820176883029504,0.0491176643441258,0.622920494215659
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35842,-0.0441278986917359,0.060802484526666,-0.163300768364001,0.0750449709805296,0.468010498912711
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35842,-0.070468087651681,0.0373228307911,-0.143620836002237,0.00268466069887489,0.0590565978929212
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35842,-0.196166637104714,0.114940423225112,-0.421449866625933,0.0291165924165044,0.0879242299301412
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35842,-0.0898990737858602,0.0734786167096042,-0.233917162536684,0.0541190149649639,0.221191055762245
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35842,-0.234990051652523,0.0846167214995681,-0.400838825791677,-0.0691412775133694,0.00549854243057005
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35842,-0.18372676706762,0.088185903549375,-0.356571138024395,-0.0108823961108451,0.0372494992528543
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35842,-0.13612483101052,0.10347204331459,-0.338930035907117,0.0666803738860774,0.188359681292118
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35842,-0.0400012804283151,0.0725026901682378,-0.182106553158061,0.102103992301431,0.581156319087711
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35842,-0.0290895969122113,0.0315759815803286,-0.0909785208096554,0.0327993269852328,0.356946905750222
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35842,-0.0530177462331345,0.0510079426035088,-0.152993313736012,0.0469578212697427,0.298652617608082
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35842,-0.205631062493418,0.0803161460336266,-0.363050708719326,-0.0482114162675094,0.010479176095443
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35842,-0.0572011024336625,0.0979207146238958,-0.249125703096498,0.134723498229173,0.559132666725128
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35842,-0.0608593126894287,0.0589257232726696,-0.176353730303861,0.0546351049250037,0.301725433481807
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35842,-0.176981527577283,0.0913626796557844,-0.35605237970262,0.00208932454805458,0.0527681072130712
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35842,-0.209876765749385,0.0890707493295161,-0.384455434435236,-0.0352980970635331,0.0184848532816306
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35842,-0.0549070187472654,0.0518213543615303,-0.156476873295865,0.0466628358013339,0.289387318263808
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35842,-0.0621212977128309,0.0487723151437603,-0.157715035394601,0.0334724399689393,0.202810633852116
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35842,-0.122579821011086,0.0726035027036126,-0.264882686310167,0.0197230442879945,0.0913879169307669
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29058.Recent feelings or nervousness or anxiety,35822,0.00593715538805515,0.0433856902253378,-0.0790987974536069,0.0909731082297172,0.891156389045054
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29059.Recent inability to stop or control worrying,35828,-0.0329825164294359,0.0461725988759089,-0.123480810226217,0.0575157773673456,0.475045632141985
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29060.Recent worrying too much about different things,35827,0.0383660269801524,0.0412385556432,-0.0424615420805195,0.119193596040824,0.352224285104966
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29061.Recent trouble relaxing,35824,-0.052228903006343,0.043741272783325,-0.13796179766166,0.0335039916489739,0.232500879981361
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29062.Recent restlessness,35831,0.0135470068985298,0.060447819092382,-0.104930718522539,0.132024732319599,0.822677450641505
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29063.Recent easy annoyance or irritability,35820,-0.0441654377523554,0.0420270768071398,-0.126538508294349,0.0382076327896385,0.293348634035762
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29064.Recent feelings of foreboding,35823,0.0130025751113932,0.0523342909342661,-0.0895726351197683,0.115577785342555,0.803791535109221
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35842,-0.0488933042040391,0.0399280918756738,-0.12715236428036,0.0293657558722815,0.220790696525784
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35842,-0.135516878807682,0.0604269781173453,-0.253953755917679,-0.0170800016976853,0.0249491852126194
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35842,-0.101886102245756,0.0847274510172823,-0.26795190623963,0.064179701748117,0.229203046165069
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35842,-0.0986436902458029,0.0833271512449148,-0.261964906685836,0.06467752619423,0.236526304292312
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#2.Symptoms of panic attack_Sweating,35842,-0.0407930456309798,0.0521615437861533,-0.14302967145184,0.0614435801898807,0.434209514681809
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35842,-0.0952440523577677,0.0643444991389886,-0.221359270670185,0.0308711659546499,0.138857887700237
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35842,0.0840329520782266,0.061745323929182,-0.0369878828229702,0.205053786979423,0.173568494002265
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35842,-0.102505095517801,0.0612327657267581,-0.222521316342247,0.0175111253066448,0.0941691419091446
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35842,-0.0898857194053405,0.078718010007062,-0.244173019019182,0.064401580208501,0.253545890536764
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29076.Felt loved as a child,35791,0.00691917447885345,0.0353632528711562,-0.0623928011486127,0.0762311501063196,0.844881815789818
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29077.Physically abused by family as a child,35803,-0.0218015341764142,0.0453601988298857,-0.11070752388299,0.0671044555301619,0.630793124333809
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29078.Felt hated by family member as a child,35796,-0.0126009200672922,0.0517232735535206,-0.113978536232193,0.0887766960976081,0.807530644633451
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29079.Sexually molested as a child,35780,-0.117803478816008,0.0749977323324828,-0.264799034187674,0.0291920765556584,0.116282362306541
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29080.Someone to take to doctor when needed as a child,35789,-0.0214964226529915,0.0541300435120573,-0.127591307936624,0.0845984626306409,0.691286682610969
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35801,0.128005491875475,0.0786099865973925,-0.0260700818554146,0.282081065606364,0.103491963787845
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35774,0.0100980556173778,0.0663846613512633,-0.120015880631098,0.140211991865854,0.879101071813091
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35812,-0.0588234259408624,0.0751200816243827,-0.206058785924652,0.0884119340429277,0.433618416854643
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35805,0.0703061099366925,0.238134413246581,-0.396437340026605,0.53704955989999,0.767821282584491
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35798,0.0400302274257028,0.145846774851761,-0.245829451283749,0.325889906135154,0.783733107636942
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29086.Experienced a violent or sexual assault,35818,-0.137329187576375,0.0792495510925936,-0.292658307717858,0.0179999325651088,0.0831614540819752
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29087.Experienced a life-threatening injury or illness,35809,0.0694164786355231,0.0402632729248114,-0.00949953629710718,0.148332493568153,0.0847390806144539
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29088.Experienced a marital separation or divorce,35809,-0.0236321113949911,0.0400421943347178,-0.102114812291038,0.0548505895010558,0.555088327108718
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29089.Experienced the death of a spouse or partner,35820,-0.0134245160442581,0.0607471300584718,-0.132488890958863,0.105639858870347,0.825106369591072
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35812,0.0903501486238408,0.0493509193477769,-0.00637765329780196,0.187077950545484,0.067176227727625
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29091.Frequency of drinking alcohol,35804,-0.0458076708147925,0.0321942904951042,-0.108908480185197,0.0172931385556117,0.154822740172463
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35213,-0.0361261983700684,0.0341952738427464,-0.103148935101851,0.0308965383617146,0.29079325237514
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35232,-0.0924711840985441,0.0341382791002024,-0.159382211134941,-0.0255601570621475,0.00677159197085305
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29104.Ever used cannabis,35799,-0.103778651074378,0.0428436786141359,-0.187752261158084,-0.0198050409906712,0.0154487275742046
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29108.Ever thought that life not worth living,35772,0.0003537064078039,0.0439544257799739,-0.0857969681209449,0.0865043809365527,0.993579622711123
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29109.Ever contemplated self-harm,35778,-0.0534956260849672,0.0614702889694594,-0.173977392465107,0.0669861402951732,0.384183062293226
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29111.Ever self-harmed,35790,-0.103290376075298,0.10762752129499,-0.314240317813478,0.107659565662883,0.337237357642467
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35791,0.0151707835154198,0.0672086301339685,-0.116558131547158,0.146899698577998,0.821420391938778
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36425,-0.0181333657201074,0.079883880131794,-0.174705770778424,0.138439039338209,0.820432349490821
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36425,-0.059976380933805,0.0618358206973583,-0.181174589500627,0.0612218276330173,0.332111659071314
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36425,-0.0379065054547475,0.0772800809236585,-0.189375464065118,0.113562453155623,0.623788155060166
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36425,-0.0226213992985579,0.125811536052568,-0.269212009961591,0.223969211364475,0.857311212094458
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35781,-0.000191632296077957,0.0373850735210937,-0.0734663763974215,0.0730831118052656,0.995910280691963
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X29153.Pain or discomfort today,35795,0.0351665763010023,0.0344279499810388,-0.0323122056618338,0.102645358263838,0.307073624528224
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29154.Anxiety or depression today,35795,0.0328042291873137,0.0459040445831849,-0.0571676981957287,0.122776156570356,0.474863295618945
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29166.Frequency of confiding in someone close,35623,0.0372057309891695,0.0341155997830885,-0.0296608445856839,0.104072306564023,0.275495942465526
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35778,0.0198216134234211,0.0163778320434304,-0.0122789373817024,0.0519221642285446,0.226214814435088
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35778,-0.0127378682357027,0.0169483290230953,-0.0459565931209695,0.0204808566495641,0.452333883796938
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35778,-0.024062049327566,0.0179994999395927,-0.0593410692091677,0.0112169705540357,0.18132453088035
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35778,-0.000340707066083131,0.0250758148173337,-0.0494893041080573,0.048807889975891,0.989159790932348
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35778,-0.138831626917333,0.04960095730006,-0.23604950322545,-0.0416137506092152,0.00514026030504547
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35778,-0.0146095304988727,0.0182385498684765,-0.0503570882410867,0.0211380272433413,0.423143810010594
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35774,0.0259299297129241,0.0191527486893263,-0.0116094577181555,0.0634693171440036,0.175827203956513
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35774,-0.010636120774375,0.030034680958371,-0.0695040954527822,0.0482318539040322,0.723253384651574
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35774,-0.023129820741141,0.0344876711230444,-0.090725656142308,0.0444660146600261,0.502452842148552
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35774,0.00625816277944377,0.042154990846583,-0.0763656192798589,0.0888819448387465,0.881987053167869
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35774,-0.0626413455813448,0.0691402406674019,-0.198156217289453,0.072873526126763,0.36496407854918
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35774,-0.0510118897710056,0.0277900684661452,-0.10548042396465,0.00345664442263905,0.066455861394893
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29171.Frequency of feeling 'in tune' with people,35597,-0.0151740126870525,0.0418443220453929,-0.0971888838960226,0.0668408585219176,0.71689214073108
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29172.Freuency of feeling that lacks companionship,35733,0.00820641666557772,0.0398020935510476,-0.0698056866944756,0.086218520025631,0.83665578260125
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29173.Frequency of feeling left out,35705,-0.00937522207349155,0.0410003546507859,-0.0897359171890319,0.0709854730420488,0.819138233042262
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29174.Frequency of feeling isolated from others,35736,0.00329503041626728,0.0418440780132008,-0.0787193624896062,0.0853094233221408,0.937237308442073
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29175.Tendency to bounce back quickly after hard times,35788,-0.0146834458080681,0.0337345945763989,-0.08080325117781,0.0514363595616738,0.663384074989886
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29176.Ability to make it through stressful events,35788,0.00738052290726248,0.0328011284980948,-0.0569096889490033,0.0716707347635282,0.821979293341815
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29177.Quick recovery from stressful events,35788,-0.00141192879203961,0.0336418264207548,-0.067349908576719,0.0645260509926398,0.96652422197238
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29178.Hard to snap back when something bad happens,35788,0.0203876603108084,0.0329130856512347,-0.0441219875656117,0.0848973081872284,0.535646607529913
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29179.Comes through difficult times with little trouble,35788,-0.0267622342872887,0.0336788309155031,-0.0927727428816748,0.0392482743070974,0.426854578175086
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29180.Tendency to take a long time to get over setbacks,35788,0.000275673776681815,0.0331138662934442,-0.0646275041584687,0.0651788517118324,0.993357898646872
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29181.General happiness,35749,0.0128479318479036,0.0341442882171671,-0.0540748730577439,0.079770736753551,0.706717326334389
SLAMF1,Signaling lymphocytic activation molecule,Mental health,X29182.Belief that own life is meaningful,35652,0.0131484536895716,0.0345646140613101,-0.0545981898705961,0.0808950972497395,0.703658376837329
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34744,0.0129025328803462,0.0351281917547862,-0.0559487229590347,0.0817537887197272,0.713409009561145
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2946.Father's age,33450,0.00135773536831931,0.0143353867472742,-0.0267396226563382,0.0294550933929768,0.924547375850158
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X2966.Age high blood pressure diagnosed,35382,-0.0314619309471705,0.0111025052675053,-0.0532228412714809,-0.0097010206228601,0.00461385073510172
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30000.White blood cell (leukocyte) count,51195,0.0139956246618124,0.00470823301955507,0.00476748794348449,0.0232237613801404,0.00295614362777387
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51196,-0.0120493296937415,0.00505980454345928,-0.0219665465989217,-0.0021321127885613,0.0172560262290948
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30020.Haemoglobin concentration,51196,-0.00266552086060138,0.0053257842619477,-0.0131040580140189,0.00777301629281611,0.616732446219128
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30030.Haematocrit percentage,51196,-0.00147280149002046,0.00522699670447027,-0.0117177150307822,0.00877211205074127,0.778123830955278
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30040.Mean corpuscular volume,51196,0.0178069519118113,0.00465939556665702,0.0086745366011635,0.026939367222459,0.000132873718295979
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51196,0.0137324624713332,0.00468091789321976,0.00455786340062246,0.0229070615420439,0.00335271954977514
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51196,-0.00413128006730464,0.00454558419175452,-0.0130406250831435,0.00477806494853422,0.363435997914318
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51196,0.0273249282723828,0.0047604938865056,0.0179943602548318,0.0366554962899338,9.59247946020888e-09
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30080.Platelet count,51196,-0.0122629580406878,0.00465568816838594,-0.0213881068507242,-0.00313780923065132,0.00844496431661983
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30090.Platelet crit,51196,-0.00156478137899632,0.00473746618660711,-0.0108502151047463,0.00772065234675362,0.741176945593866
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51196,0.0190341747657188,0.00440279527902977,0.0104046960188204,0.0276636535126171,1.54438389872022e-05
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30110.Platelet distribution width,51196,0.0187068783138717,0.00451388603175386,0.00985966169163414,0.0275540949361093,3.42100837941021e-05
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30120.Lymphocyte count,51159,-0.0111995043881785,0.0045740566825118,-0.0201646554859016,-0.00223435329045533,0.014353441236642
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30130.Monocyte count,51159,0.0388232513121693,0.0045765834052117,0.0298531478379544,0.0477933547863842,2.32722026002579e-17
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30140.Neutrophill count,51159,0.0116625394706249,0.00464603294824459,0.00255631489206551,0.0207687640491843,0.0120727241851131
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30150.Eosinophill count,51159,0.0300279763229989,0.00442427171202619,0.0213564037674275,0.0386995488785702,1.17246566789602e-11
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30160.Basophill count,51159,0.0523772246977311,0.0206503304609595,0.0119025769942504,0.0928518724012117,0.0112069804735061
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30170.Nucleated red blood cell count,51159,0.140092069652613,0.104133909578582,-0.0640103931214073,0.344194532426633,0.178539661324527
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30180.Lymphocyte percentage,51160,-0.0241814825649169,0.00451881117896095,-0.0330383524756804,-0.0153246126541535,8.81796674565186e-08
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30190.Monocyte percentage,51160,0.0325174904300995,0.00452612048087446,0.0236462942875855,0.0413886865726134,6.95978529218745e-13
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30200.Neutrophill percentage,51160,0.00332463311447608,0.00445616890269506,-0.00540945793480622,0.0120587241637584,0.455630304304247
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30210.Eosinophill percentage,51160,0.0267465158661758,0.00438129512702276,0.0181591774172112,0.0353338543151405,1.04671476071961e-09
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30220.Basophill percentage,51160,0.00918586345403195,0.00457758373188294,0.000213799339541378,0.0181579275685225,0.0447929166270196
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30230.Nucleated red blood cell percentage,51158,0.147080205064347,0.104444498725509,-0.0576310124376512,0.351791422566345,0.15908149456387
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30240.Reticulocyte percentage,50820,0.0139124393839421,0.00484192072321045,0.00442227476644959,0.0234026040014345,0.00406553563280307
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30250.Reticulocyte count,50820,0.0112134788438281,0.0048826639881045,0.00164345742714326,0.0207835002605129,0.0216514092847011
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30260.Mean reticulocyte volume,50820,0.0267025190490226,0.00456934340565987,0.0177466059739293,0.035658432124116,5.17228294548899e-09
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30270.Mean sphered cell volume,50820,0.0185480011505723,0.00459772150602916,0.00953646699875516,0.0275595353023895,5.49782454967932e-05
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30280.Immature reticulocyte fraction,50820,0.0120180942225082,0.00475805191774449,0.00269231246372903,0.0213438759812874,0.0115489812486556
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50820,0.0163383982182816,0.00490345802471215,0.00672762048984577,0.0259491759467174,0.000863600818838561
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30300.High light scatter reticulocyte count,50820,0.0143949636973635,0.0049206625621206,0.00475046507560711,0.0240394623191199,0.00344348712483791
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30500.Microalbumin in urine,36908,0.0653682942474446,0.00719531099000743,0.0512654847070301,0.0794711037878592,1.27925918139522e-19
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51249,-0.000374321861030342,0.00491214228248705,-0.010002120734705,0.00925347701264427,0.939257964122262
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30520.Potassium in urine,51202,-0.0130042100878487,0.00458287889406954,-0.021986652720225,-0.00402176745547242,0.00454997624945423
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30530.Sodium in urine,51215,-0.00973151935738884,0.00474240026263938,-0.019026623872162,-0.000436414842615666,0.0401788132284339
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30600.Albumin,49074,-0.0702678036975415,0.00483405723819775,-0.0797425558844091,-0.060793051510674,1.237955595651e-47
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30610.Alkaline phosphatase,50764,0.0760610698742082,0.0047721471988508,0.0667076613644606,0.0854144783839558,7.08834777015474e-57
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30620.Alanine aminotransferase,50749,0.0251754914115713,0.00516785774817012,0.0150464902251579,0.0353044925979847,1.11488977217378e-06
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30630.Apolipoprotein A,49013,-0.0619163715340794,0.00523064064313902,-0.0721684271946319,-0.0516643158735269,3.19395509279948e-32
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30640.Apolipoprotein B,50600,-0.0368296241140897,0.00448338246670817,-0.0456170537488378,-0.0280421944793417,2.24316108961539e-16
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30650.Aspartate aminotransferase,50686,0.0409038657019054,0.00475485003973937,0.0315843596240163,0.0502233717797946,8.30721342135253e-18
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30660.Direct bilirubin,49226,0.0199628807042366,0.00486521243784554,0.0104270643260593,0.0294986970824139,4.09061257772862e-05
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30670.Urea,50749,0.0179111256329643,0.00468877207316087,0.00872113236956895,0.0271011188963596,0.000133813878062677
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30680.Calcium,49065,-0.0216955122289573,0.00480593852685905,-0.031115151741601,-0.0122758727163135,6.38763508065968e-06
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30690.Cholesterol,50767,-0.0498994690016831,0.00450945245229201,-0.0587379958081754,-0.0410609421951907,2.188066917211e-28
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30700.Creatinine,50757,0.0322063317730095,0.00584564871608195,0.0207488602894889,0.0436638032565301,3.63952638639064e-08
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30710.C-reactive protein,50686,0.0609443564445077,0.0049991755543642,0.0511459723579539,0.0707427405310615,4.47380577847585e-34
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30720.Cystatin C,50772,0.118656032994221,0.00535005240853129,0.1081699302735,0.129142135714942,8.24113907048452e-108
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30730.Gamma glutamyltransferase,50750,0.0358750881114201,0.0054571695917727,0.0251790357115456,0.0465711405112946,5.00929027779023e-11
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30740.Glucose,49040,0.0307511245009153,0.00457963875355247,0.0217750325439525,0.0397272164578782,1.93337053502864e-11
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50663,0.0276816836592646,0.00463069117574197,0.0186055289548104,0.0367578383637189,2.29544824867278e-09
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30760.HDL cholesterol,49052,-0.0683086175773982,0.00541631068771243,-0.0789245865253146,-0.0576926486294818,2.48705732537261e-36
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30770.IGF-1,50661,-0.0394734979481701,0.00478952187592249,-0.0488609608249782,-0.030086035071362,1.7924323771017e-16
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30780.LDL direct,50718,-0.043470846440175,0.00450350236634208,-0.0522977110782055,-0.0346439818021446,5.29233038501732e-22
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30790.Lipoprotein A,46270,-0.0128629654172804,0.00496671960907043,-0.0225977358510585,-0.00312819498350241,0.00961017859373284
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30810.Phosphate,49013,-0.0141177465211581,0.00470011667153353,-0.0233299751973638,-0.00490551784495234,0.00267040330992056
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30830.SHBG,48923,0.0246729237448839,0.00624401685371685,0.0124346507115989,0.036911196778169,7.79414169592807e-05
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30840.Total bilirubin,50675,0.0022214451320177,0.00493113933917588,-0.00744358797276702,0.0118864782368024,0.652359223294235
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30850.Testosterone,50537,0.0136603099407,0.00773612328998484,-0.00150249170767024,0.0288231115890703,0.0774462791760024
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30860.Total protein,49044,0.0610159769369699,0.00475674567789079,0.051692755408304,0.0703391984656359,1.61024862926224e-37
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30870.Triglycerides,50742,0.0141800271925414,0.00473243821417047,0.00490444829276729,0.0234556060923155,0.00273537881984674
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30880.Urate,50735,0.0354974504787526,0.0056711257296508,0.0243820440486371,0.0466128569088682,3.93731356358542e-10
SLAMF1,Signaling lymphocytic activation molecule,Blood and urine assays,X30890.Vitamin D,50088,-0.0137055876889073,0.00510349919108264,-0.0237084461034292,-0.00370272927438529,0.00724710150647851
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3137.Number of measurements made,49488,-0.00928628343265051,0.0247820730987115,-0.057859146706125,0.0392865798408239,0.707874171451086
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3143.Ankle spacing width,41776,0.00298524807685733,0.00809735114180738,-0.0128855601610851,0.0188560563147998,0.712379853841451
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",41775,-0.0139108824995888,0.00589784616280007,-0.0254706609786769,-0.00235110402050063,0.0183566706779454
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3146.Speed of sound through heel,41776,-0.0135890346920897,0.00569440262670097,-0.0247500638404236,-0.00242800554375575,0.0170289756188531
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",41776,-0.0142329988338264,0.00574919077691119,-0.0255014127565723,-0.00296458491108047,0.0133117674450826
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X3148.Heel bone mineral density (BMD),41756,-0.015702691229687,0.00578559496568245,-0.0270424573624246,-0.00436292509694942,0.00665424164088848
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X3526.Mother's age at death,42521,-0.00636133848597686,0.00592748824919815,-0.0179792154544052,0.00525653848245152,0.283203164369104
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32883,-0.000728672846044604,0.0105248081818146,-0.0213572968824012,0.019899951190312,0.944806722312368
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4100.Ankle spacing width (left),36035,0.00961276799337195,0.0113336654738545,-0.0126012163353828,0.0318267523221267,0.396375865542465
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36033,-0.0199889328153804,0.00819589860127181,-0.0360528940738732,-0.00392497155688765,0.0147555063205967
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4103.Speed of sound through heel (left),36035,-0.0219562170321069,0.00785806202330233,-0.0373580185977794,-0.00655441546643429,0.005217751011034
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36035,-0.0218552484576997,0.00796369932793426,-0.0374640991404508,-0.00624639777494852,0.00607747270053829
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4105.Heel bone mineral density (BMD) (left),36025,-0.021531073853698,0.00800517671171801,-0.0372212202086653,-0.00584092749873073,0.00716882177109345
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36035,-0.0218685449313774,0.00796418613993466,-0.0374783497656493,-0.00625874009710544,0.00604975219080862
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4119.Ankle spacing width (right),36023,0.00861573960891662,0.011128452637291,-0.0131960275601738,0.0304275067780071,0.438832319993513
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36022,-0.0193169368130894,0.00826577603927586,-0.0355178578500701,-0.0031160157761087,0.0194667820054468
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4122.Speed of sound through heel (right),36023,-0.019563231601673,0.00785386415518267,-0.034956805345831,-0.00416965785751496,0.0127634905236125
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36023,-0.0198413791283374,0.00798845952441047,-0.0354987597961819,-0.00418399846049288,0.0130224074406447
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4124.Heel bone mineral density (BMD) (right),36012,-0.0190375207531757,0.0080221109214438,-0.0347608581592056,-0.00331418334714585,0.0176633591266682
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36023,-0.0198383148532282,0.0079884629346241,-0.0354957022050914,-0.00418092750136493,0.0130364673290101
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4194.Pulse rate,36403,0.0241152539088538,0.00738261426742668,0.00964532994469746,0.0385851778730101,0.00109358997607185
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4195.Pulse wave reflection index,36403,-0.00738350174161455,0.00774888407884144,-0.0225713145361438,0.00780431105291467,0.340697059461476
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4196.Pulse wave peak to peak time,36395,-0.0171317067562293,0.00853317338659435,-0.0338567265939543,-0.000406686918504408,0.0447139326455086
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4198.Position of the pulse wave peak,36403,0.0129008910244899,0.00924660074299768,-0.00522244643178559,0.0310242284807653,0.16299414620092
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4199.Position of pulse wave notch,36403,0.0136815689695945,0.00749389014804413,-0.00100645572057195,0.028369593659761,0.0679341923281718
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4200.Position of the shoulder on the pulse waveform,36403,0.024706686306397,0.00941605386423236,0.00625122073250161,0.0431621518802925,0.00871011908237963
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4269.Number of triplets attempted (left),36190,0.173153397095584,0.0975659554583497,-0.0180758756027818,0.364382669793949,0.0759823396932963
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4270.Volume level set by participant (left),36103,0.0262362683676038,0.0311548904312067,-0.0348273168775613,0.0872998536127689,0.399745626456435
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4276.Number of triplets attempted (right),36192,0.152570737360359,0.0964273054916477,-0.0364267814032707,0.341568256123988,0.11363747069054
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X4277.Volume level set by participant (right),36103,0.0656857082103518,0.0313537787802975,0.00423230180096876,0.127139114619735,0.0362057496453628
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X4288.Time to answer,36371,-0.00532605918095532,0.0087981253513113,-0.0225703848695255,0.0119182665076148,0.544955536125558
SLAMF1,Signaling lymphocytic activation molecule,Cognitive function,X4290.Duration screen displayed,36371,0.0246090779543913,0.00824560232311786,0.0084476974010803,0.0407704585077023,0.00284917318006416
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X46.Hand grip strength (left),51788,-0.0255671427793995,0.0060008400552198,-0.0373287892876303,-0.0138054962711687,2.04688164644748e-05
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X47.Hand grip strength (right),51787,-0.0264108507341057,0.00592011460584219,-0.0380142753615564,-0.014807426106655,8.18828075746774e-06
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X48.Waist circumference,51841,0.0417975822769495,0.0112049505530791,0.0198358791929145,0.0637592853609845,0.000191723206268056
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X4803.Tinnitus,36223,0.0282724489622297,0.0358161301683752,-0.0419271661677857,0.098472064092245,0.429915935807724
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X4825.Noisy workplace,36300,0.0447223251625794,0.0345401026690668,-0.0229762760687915,0.11242092639395,0.195430061419595
SLAMF1,Signaling lymphocytic activation molecule,Working and living environment,X4836.Loud music exposure frequency,36249,-0.0434773075354534,0.0460770634745023,-0.133788351945478,0.0468337368745711,0.345415102760704
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X49.Hip circumference,51836,-0.00552490508968223,0.0082727614186575,-0.0217395174702509,0.0106897072908865,0.504240503362094
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X50.Standing height,51794,0.00756931893045618,0.00626137237093963,-0.00470297091658549,0.0198416087774978,0.226716911176996
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X5057.Number of older siblings,35383,0.0186209782656815,0.0332086597425052,-0.0464679948296286,0.0837099513609917,0.575002466597063
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,X51.Seated height,51694,0.0106631291410415,0.00545417677983625,-2.70573474375983e-05,0.0213533156295205,0.0505904945186624
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5181.Ever had eye surgery,33831,0.0349253501568002,0.0768989346967533,-0.115796561848836,0.185647262162437,0.649723817635307
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5186.Duration visual-acuity screen displayed (right),33820,0.00290068703893917,0.00953467090200427,-0.0157872679289892,0.0215886420068675,0.760968463763319
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5188.Duration visual-acuity screen displayed (left),33816,0.00437171515526599,0.00980795471151043,-0.0148518760792944,0.0235953063898264,0.65580964924265
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5190.Duration at which refractometer first shown (right),33764,0.00714539450006132,0.00984397625461019,-0.0121487989589747,0.0264395879590973,0.467954636493407
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5193.Duration at which refractometer first shown (left),33760,0.00830094181123802,0.00988575168942014,-0.0110751315000255,0.0276770151225015,0.401122543662248
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5199.logMAR, initial (right)",33799,0.0178981845808384,0.0387839124083357,-0.0581182837394996,0.0939146529011764,0.644470161997
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5200.Final number of letters displayed (right),33799,0.349718314852169,0.225436635799148,-0.092137491314161,0.7915741210185,0.120892331845505
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5201.logMAR, final (right)",33740,-0.000721710799924217,0.00942961581774647,-0.0192037578027073,0.0177603362028589,0.938995169997772
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5202.Number of rounds to result (right),33799,-0.00650381441200911,0.0368513146421559,-0.0787323911106347,0.0657247622866164,0.859917472765253
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5206.logMAR, initial (left)",33794,0.0531046060599731,0.0394100424591058,-0.0241390771598743,0.130348289279821,0.1778815200348
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5207.Final number of letters displayed (left),33794,-0.00779394849134381,0.238285549316811,-0.474833625152293,0.459245728169606,0.973908350951247
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5208.logMAR, final (left)",33748,0.00692403875315436,0.00951995660138288,-0.0117350761855561,0.0255831536918648,0.467064057588575
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5209.Number of rounds to result (left),33790,0.0415506491264649,0.0369409969473089,-0.0308537048902606,0.11395500314319,0.26073262390673
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33596,-0.0210485132915571,0.00939095811931778,-0.0394547912054199,-0.00264223537769423,0.0250465347774056
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33596,-0.014795180938778,0.00922291905135115,-0.0328721022794263,0.00328174040187022,0.108738578199499
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5256.Corneal hysteresis (right),33596,0.0107932220696169,0.00957215474323432,-0.00796820122712241,0.0295546453663561,0.259558026512788
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5257.Corneal resistance factor (right),33596,-0.000560562844003143,0.00944601086247505,-0.0190747441344542,0.017953618446448,0.952680592647885
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33572,-0.0119513527998702,0.00949737068705777,-0.0305661993465034,0.00666349374676307,0.208311489439141
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33572,-0.0138904963883573,0.00938822140925904,-0.0322914103505051,0.00451041757379038,0.139052369075994
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5264.Corneal hysteresis (left),33572,0.00159613443438342,0.00950616804724667,-0.01703595493822,0.0202282238069869,0.8666647388723
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X5265.Corneal resistance factor (left),33572,-0.00474341824714005,0.00943761871113055,-0.0232411509209559,0.0137543144266758,0.615262492883464
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34481,0.134483349855702,0.181926849716444,-0.222093275588528,0.491059975299931,0.459804981560641
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51773,0.0204616590059569,0.0244759165647894,-0.0275111374610304,0.0684344554729442,0.403168286287415
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51773,0.0343894775658629,0.0284763825642368,-0.0214242322600413,0.090203187391767,0.227194592519262
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51773,0.145022512084918,0.0705513831782603,0.0067418010555281,0.283303223114308,0.0398362484157908
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51773,-0.00460166064416235,0.0111259042075866,-0.0264084328910322,0.0172051116027074,0.679171778675594
SLAMF1,Signaling lymphocytic activation molecule,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51773,-0.0132266688744238,0.0103180108010797,-0.03344997004454,0.00699663229569236,0.199890184772336
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38734,0.00449972615176719,0.013363050115022,-0.0216918520736759,0.0306913043772103,0.736328192347172
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38734,0.0294257423756622,0.0414545683707223,-0.0518252116309536,0.110676696382278,0.477825205292301
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38734,-0.0105666536590494,0.0256738337590684,-0.0608873678268236,0.0397540605087247,0.680661218046107
SLAMF1,Signaling lymphocytic activation molecule,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38734,0.0129364221936136,0.0155175848317857,-0.0174780440766864,0.0433508884639136,0.404491075446096
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51842,0.039827653900165,0.0235253269965524,-0.00628198701307763,0.0859372948134076,0.0904747326300879
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51842,0.039827653900165,0.0235253269965524,-0.00628198701307763,0.0859372948134076,0.0904747326300879
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51842,0.0107303555496176,0.017196142448014,-0.0229740836484899,0.0444347947477251,0.532635135295139
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51842,-0.0384736389888851,0.0303179774928909,-0.0978968748749513,0.0209495968971811,0.204452295146252
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51842,-0.0456394624278488,0.0706114333336704,-0.184037871761843,0.0927589469061451,0.518061273456077
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51842,0.0772301033162912,0.0500525102505658,-0.0208728167748178,0.1753330234074,0.12284885014969
SLAMF1,Signaling lymphocytic activation molecule,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51842,-0.0432690110736839,0.0754519201251673,-0.191154774519012,0.104616752371644,0.566335657133865
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51772,0.0215516845038027,0.0153508813132374,-0.00853604287014267,0.0516394118777481,0.160350735970503
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51772,0.00832907872105795,0.0269497440140197,-0.0444924195464206,0.0611505769885365,0.757278923268638
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51772,-0.0188666661647382,0.0139826281788903,-0.0462726173953631,0.00853928506588674,0.177255968165953
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51772,0.0305675539195408,0.0206409797445465,-0.00988876637977047,0.071023874218852,0.138642597238835
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51772,0.0230187415917982,0.0208580038917515,-0.0178629460360348,0.0639004292196311,0.26978130380983
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51772,0.049395035509269,0.0117785896017357,0.0263089998898671,0.0724810711286708,2.75546382153508e-05
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,36969,0.000204421608821309,0.0222561185608988,-0.0434175707705403,0.0438264139881829,0.992671782396336
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,36969,-0.0306721655830322,0.0211484904377115,-0.0721232068409469,0.0107788756748824,0.147005634105361
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,36969,0.05135843275078,0.030839580439429,-0.00908714491050085,0.111804010412061,0.0958820748284394
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,36969,0.0477391928389222,0.0230159442607085,0.00262794208793361,0.0928504435899108,0.038093173405132
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51723,0.101748030062462,0.0409733306331201,0.0214403020215463,0.182055758103377,0.0130251033398765
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51723,0.0648199173685203,0.0510127483654403,-0.0351650694277425,0.164804904164783,0.203862007072035
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51723,0.436050691887733,0.10358681348899,0.233020537449313,0.639080846326153,2.56880879232296e-05
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51723,0.238092918603626,0.0977780162766826,0.046448006701328,0.429737830505924,0.0148978460631463
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51723,0.0677286495953398,0.0389020013078242,-0.00851927296799559,0.143976572158675,0.0816956834404663
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51723,0.0511897331087384,0.0457318277561912,-0.0384446492933964,0.140824115510873,0.263004235741176
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51723,0.0180590073370825,0.0193096820577723,-0.0197879694961513,0.0559059841703163,0.349679190459555
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35529,0.0659117044524043,0.0325765035443486,0.00206175750548111,0.129761651399327,0.043081604643181
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35529,0.0710824439402918,0.0316311448248553,0.00908540008357534,0.133079487797008,0.0246566987779244
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35529,0.0592254954872524,0.0455035383797918,-0.0299614397371396,0.148412430711644,0.19311078881315
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35529,0.0249623709756882,0.0163438772978165,-0.00707162852803217,0.0569963704794086,0.126726489795441
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38624,0.00229395884777866,0.014161726329599,-0.0254630247582353,0.0300509424537926,0.871322509674946
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38624,-0.00775082226502721,0.0156996205463449,-0.0385220785358632,0.0230204340058088,0.621532499079209
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38624,-0.00122658494747786,0.0138834537007087,-0.0284381542008669,0.0259849843059112,0.92960130605822
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38625,-0.00437399456578396,0.0323977128253711,-0.0678735117035113,0.0591255225719434,0.892607182088431
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38625,0.0355783262994002,0.0192081512393502,-0.00206965012972612,0.0732263027285265,0.0640190974379889
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38625,0.0460648753887232,0.0351146165069341,-0.0227597729648678,0.114889523742314,0.189603041435859
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51772,-0.0664378155767807,0.0302149992547021,-0.125659214115997,-0.00721641703756464,0.0278994616459975
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51772,0.0139338274595571,0.0242451815360073,-0.0335867283510172,0.0614543832701313,0.565496393380881
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51772,0.137896513794981,0.0490065105506604,0.0418437531156862,0.233949274474275,0.00489947146319212
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51772,-0.0845744766784528,0.0272169882077056,-0.137919773565556,-0.0312291797913498,0.00188959447934427
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51772,-0.0544201055992717,0.0278357088087195,-0.108978094864362,0.000137883665818413,0.0505895843802507
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51772,0.030729111629593,0.0334516468896602,-0.0348361162741411,0.0962943395333271,0.358307686451437
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51772,0.0276528270899977,0.00975544522644783,0.00853215444615996,0.0467734997338354,0.00459221638487413
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34118,0.0529881094758247,0.0244817018750638,0.00500397380069976,0.10097224515095,0.0304766856964172
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34118,0.130173218180253,0.0293922731240399,0.0725643628571353,0.187782073503372,9.65782331883654e-06
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34118,-0.0459714572084586,0.0218162309273702,-0.0887312698261042,-0.00321164459081304,0.0351440811753129
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34118,-0.0072984637785661,0.0193104676280794,-0.0451469803296018,0.0305500527724696,0.7054794849582
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51877,0.0131063577636519,0.0118649937001437,-0.0101490298886298,0.0363617454159336,0.269333930089462
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51877,0.0563915908600231,0.0389292264275842,-0.0199096929380419,0.132692874658088,0.147472026012063
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51877,-0.00967574429212183,0.010438790410594,-0.030135773496886,0.0107842849126424,0.353986602039202
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51877,0.00505237392418679,0.00975209319718975,-0.0140617287423051,0.0241664765906787,0.604406699574242
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51877,0.0540114102744755,0.0164771099189237,0.0217162748333849,0.086306545715566,0.00104711123854586
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51877,0.035088495759504,0.0148853926022702,0.00591312625905433,0.0642638652599536,0.0184193983404711
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51877,-0.0173059107737204,0.0105082302860063,-0.0379020421342928,0.0032902205868519,0.0995939335382862
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51877,0.0636069446962934,0.0342159211413834,-0.00345626074081815,0.130670150133405,0.0630416244456155
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,44808,-0.0495004433124981,0.0108073418506944,-0.070682833339859,-0.0283180532851371,4.67854490920122e-06
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,44808,0.00180647267764596,0.0106365133164153,-0.019041093422528,0.0226540387778199,0.865140509181887
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,44808,0.00781306249838642,0.0137777607958153,-0.0191913486614115,0.0348174736581844,0.570669167541169
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,44809,-0.0226568323351939,0.0213914670296947,-0.0645841077133954,0.0192704430430076,0.289545976879017
SLAMF1,Signaling lymphocytic activation molecule,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,44809,0.00138779912040939,0.0121623533748235,-0.0224504134942446,0.0252260117350634,0.909155073242282
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51657,-0.0215125037776708,0.0112200462050821,-0.0435037943396317,0.00047878678429001,0.055208673648108
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51657,-0.0238358193203422,0.00880956842793879,-0.0411025734391023,-0.00656906520158222,0.00682160579267085
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51657,0.0145712314260939,0.00994394644483888,-0.00491890360579034,0.0340613664579781,0.142842665753806
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51657,-0.00980735718929548,0.0151787015147943,-0.0395576121582923,0.0199428977797013,0.518204040013954
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51679,-0.0319795527161562,0.00948441586449535,-0.0505690078105671,-0.0133900976217453,0.000748012301219184
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51679,-0.0489664429886182,0.0132299526300374,-0.0748971501434915,-0.0230357358337449,0.000215097587979402
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51772,-0.0454854413275067,0.00967494552238464,-0.0644483345513806,-0.0265225481036328,2.5991593042913e-06
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51772,-0.0558526092653653,0.01215139795204,-0.0796693492513636,-0.0320358692793669,4.3213334398713e-06
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51772,-0.0369032661488669,0.0259238981903099,-0.0877141066018743,0.0139075743041405,0.154598054301411
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51772,-0.0722849307542311,0.0238163556735698,-0.118964987874428,-0.0256048736340343,0.00240725658156791
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51772,-0.0516644738020981,0.0286674583946505,-0.107852692255613,0.00452374465141691,0.0715270432206613
SLAMF1,Signaling lymphocytic activation molecule,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51772,-0.0591259717611577,0.0296538009844781,-0.117247421690735,-0.00100452183158053,0.0461774191662833
SLAMF1,Signaling lymphocytic activation molecule,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",41776,-0.0142311043673799,0.0057492116499021,-0.025499559201188,-0.00296264953357182,0.0133243864190048
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X864.Number of days or week walked 10+ minutes,51412,-0.0313153157338617,0.0184646181617865,-0.0675059673309632,0.00487533586323987,0.08990646892428
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X874.Duration of walks,48791,-0.00221232543833552,0.00454667285405361,-0.0111238042322806,0.00669915335560956,0.626560445269797
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50823,-0.0290572309373181,0.0177026658993566,-0.063754456100057,0.00563999422542081,0.100727683845725
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X894.Duration of moderate activity,46103,-0.000100874424354774,0.0212070690991368,-0.0416667298586629,0.0414649810099534,0.996204817732547
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X90087.No-wear time bias adjusted average acceleration,33238,-0.00496699185496841,0.0100947212504848,-0.0247526455059185,0.0148186617959817,0.622715389590229
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50752,-0.0663875336288541,0.0182715195149715,-0.102199711878198,-0.03057535537951,0.000280355313245233
SLAMF1,Signaling lymphocytic activation molecule,Physical activities,X914.Duration of vigorous activity,41857,-0.0038486716267337,0.00537232652238015,-0.0143784316105988,0.00668108835713139,0.473764263919767
